| Year |
Citation |
Score |
| 2023 |
Grasemann H, Ratjen F. Cystic Fibrosis. The New England Journal of Medicine. 389: 1693-1707. PMID 37913507 DOI: 10.1056/NEJMra2216474 |
0.373 |
|
| 2023 |
Blanchard AC, Shaw M, Ratjen F, Tullis E, Daneman N, Waters V. Factors associated with lung function response with oral antibiotic treatment of pulmonary exacerbations in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 37474423 DOI: 10.1016/j.jcf.2023.06.015 |
0.393 |
|
| 2023 |
Chen Y, Lv Q, Andrinopoulou ER, Gallardo-Estrella L, Charbonnier JP, Caudri D, Davis SD, Rosenfeld M, Ratjen F, Kronmal RA, Stukovsky KDH, Stick S, Tiddens HAWM. Automatic bronchus and artery analysis on chest computed tomography to evaluate the effect of inhaled hypertonic saline in children aged 3-6 years with cystic fibrosis in a randomized clinical trial. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 37246053 DOI: 10.1016/j.jcf.2023.05.013 |
0.536 |
|
| 2023 |
Perrem L, Martin I, Ratjen F. Outpatient management of pulmonary exacerbations in children with cystic fibrosis. Expert Review of Respiratory Medicine. PMID 37043239 DOI: 10.1080/17476348.2023.2202852 |
0.431 |
|
| 2023 |
Goralski JL, Hoppe JE, Mall MA, McColley SA, McKone E, Ramsey B, Rayment JH, Robinson P, Stehling F, Taylor-Cousar JL, Tullis E, Ahluwalia N, Chin A, Chu C, Lu M, ... ... Ratjen F, et al. Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2 Through 5 Years with Cystic Fibrosis and at Least One Allele. American Journal of Respiratory and Critical Care Medicine. PMID 36921081 DOI: 10.1164/rccm.202301-0084OC |
0.316 |
|
| 2023 |
Licht JC, Seidl E, Slingers G, Waters V, de Vries R, Post M, Ratjen F, Grasemann H. Exhaled breath profiles to detect lung infection with Staphylococcus aureus in children with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 36849333 DOI: 10.1016/j.jcf.2023.02.010 |
0.323 |
|
| 2023 |
Alam FS, Zanette B, Munidasa S, Braganza S, Li D, Woods JC, Ratjen F, Santyr G. Intra- and Inter-visit Repeatability of Xenon Multiple-Breath Washout MRI in Children With Stable Cystic Fibrosis Lung Disease. Journal of Magnetic Resonance Imaging : Jmri. PMID 36786650 DOI: 10.1002/jmri.28638 |
0.406 |
|
| 2023 |
Streibel C, Willers CC, Pusterla O, Bauman G, Stranzinger E, Brabandt B, Bieri O, Curdy M, Bullo M, Frauchiger BS, Korten I, Krüger L, Casaulta C, Ratjen F, Latzin P, et al. Effects of elexacaftor/tezacaftor/ivacaftor therapy in children with cystic fibrosis - a comprehensive assessment using lung clearance index, spirometry, and functional and structural lung MRI. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 36635199 DOI: 10.1016/j.jcf.2022.12.012 |
0.391 |
|
| 2022 |
Munidasa S, Zanette B, Couch M, Grimm R, Seethamraju R, Dumas MP, Wee W, Au J, Braganza S, Li D, Woods J, Ratjen F, Santyr G. Inter- and intravisit repeatability of free-breathing MRI in pediatric cystic fibrosis lung disease. Magnetic Resonance in Medicine. PMID 36576212 DOI: 10.1002/mrm.29566 |
0.37 |
|
| 2022 |
Bowerman C, Ratjen F, Stanojevic S. Estimating the minimum sample size for interventional and observational studies using the lung clearance index as an endpoint. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 36402729 DOI: 10.1016/j.jcf.2022.11.003 |
0.334 |
|
| 2022 |
Britto CJ, Ratjen F, Clancy JP. Emerging Approaches to Monitor and Modify Care in the Era of Cystic Fibrosis Transmembrane Conductance Regulators. Clinics in Chest Medicine. 43: 631-646. PMID 36344071 DOI: 10.1016/j.ccm.2022.06.006 |
0.331 |
|
| 2022 |
Casaredi IG, Shaw M, Waters V, Seeto R, Blanchard A, Ratjen F. Impact of antibiotic eradication therapy of Pseudomonas aeruginosa on long term lung function in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 35995678 DOI: 10.1016/j.jcf.2022.08.007 |
0.33 |
|
| 2022 |
Perrem L, Stanojevic S, Shaw M, Pornillos M, Guido J, Sanders DB, Solomon M, Grasemann H, Sweezey N, Waters V, Davis SD, Ratjen F. Comparative analysis of respiratory symptom scores to detect acute respiratory events in children with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 35753986 DOI: 10.1016/j.jcf.2022.06.007 |
0.547 |
|
| 2022 |
Zikic A, Ratjen F, Shaw M, Tullis E, Waters V. The effect of antibiotic changes during treatment of cystic fibrosis pulmonary exacerbations. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 35650003 DOI: 10.1016/j.jcf.2022.05.010 |
0.378 |
|
| 2022 |
Perrem L, Stanojevic S, Solomon M, Grasemann H, Sweezey N, Waters V, Sanders DB, Davis SD, Ratjen F. Evaluation of clinically relevant changes in the lung clearance index in children with cystic fibrosis and healthy controls. Thorax. PMID 35428702 DOI: 10.1136/thoraxjnl-2021-218347 |
0.6 |
|
| 2022 |
Gong J, He G, Wang C, Bartlett C, Panjwani N, Mastromatteo S, Lin F, Keenan K, Avolio J, Halevy A, Shaw M, Esmaeili M, Côté-Maurais G, Adam D, Bégin S, ... ... Ratjen F, et al. Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease. Npj Genomic Medicine. 7: 28. PMID 35396391 DOI: 10.1038/s41525-022-00299-9 |
0.351 |
|
| 2022 |
Tiddens HAWM, Chen Y, Andrinopoulou ER, Davis SD, Rosenfeld M, Ratjen F, Kronmal RA, Hinckley Stukovsky KD, Dasiewicz A, Stick SM. The effect of inhaled hypertonic saline on lung structure in children aged 3-6 years with cystic fibrosis (SHIP-CT): a multicentre, randomised, double-blind, controlled trial. The Lancet. Respiratory Medicine. PMID 35286860 DOI: 10.1016/S2213-2600(21)00546-4 |
0.584 |
|
| 2022 |
Jacobi E, Solomon M, Avolio J, Shaw M, Gonska T, Ratjen F, Grasemann H. Aquagenic wrinkling of the palms in cystic fibrosis patients treated with ivacaftor. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 35063397 DOI: 10.1016/j.jcf.2022.01.005 |
0.338 |
|
| 2021 |
Gonska T, Keenan K, Au J, Dupuis A, Chilvers MA, Burgess C, Bjornson C, Fairservice L, Brusky J, Kherani T, Jober A, Kosteniuk L, Price A, Itterman J, Morgan L, ... ... Ratjen F, et al. Outcomes of Cystic Fibrosis Screening-Positive Infants With Inconclusive Diagnosis at School Age. Pediatrics. PMID 34814176 DOI: 10.1542/peds.2021-051740 |
0.312 |
|
| 2021 |
Dumas MP, Xia S, Bear CE, Ratjen F. Perspectives on the translation of in-vitro studies to precision medicine in Cystic Fibrosis. Ebiomedicine. 73: 103660. PMID 34740114 DOI: 10.1016/j.ebiom.2021.103660 |
0.327 |
|
| 2021 |
Donaldson SH, Laube BL, Mogayzel P, Corcoran TE, Pilewski JM, Ceppe A, Wu J, Bhambhvani PG, Ratjen F, Sagel SD, Clancy JP, Rowe SM, Bennett WD. Effect of lumacaftor-ivacaftor on mucociliary clearance and clinical outcomes in cystic fibrosis: Results from the PROSPECT MCC sub-study. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 34083123 DOI: 10.1016/j.jcf.2021.05.004 |
0.382 |
|
| 2021 |
Bayfield KJ, Douglas TA, Rosenow T, Davies JC, Elborn SJ, Mall M, Paproki A, Ratjen F, Sly PD, Smyth AR, Stick S, Wainwright CE, Robinson PD. Time to get serious about the detection and monitoring of early lung disease in cystic fibrosis. Thorax. PMID 33927017 DOI: 10.1136/thoraxjnl-2020-216085 |
0.413 |
|
| 2021 |
Mondéjar-López P, Horsley A, Ratjen F, Bertolo S, de Vicente H, Asensio de la Cruz Ò. A multimodal approach to detect and monitor early lung disease in cystic fibrosis. Expert Review of Respiratory Medicine. 1-12. PMID 33843417 DOI: 10.1080/17476348.2021.1908131 |
0.355 |
|
| 2021 |
Pollak M, Shaw M, Wilson D, Solomon M, Ratjen F, Grasemann H. Bronchodilator Responsiveness in Cystic Fibrosis Children Treated for Pulmonary Exacerbations. Pediatric Pulmonology. PMID 33830642 DOI: 10.1002/ppul.25409 |
0.421 |
|
| 2021 |
Stanojevic S, Davis SD, Perrem L, Shaw M, Retsch-Bogart G, Davis M, Jensen R, Clem CC, Isaac SM, Guido J, Jara S, France L, McDonald N, Solomon M, Sweezey N, ... ... Ratjen FA, et al. Determinants of lung disease progression measured by lung clearance index in children with cystic fibrosis. The European Respiratory Journal. PMID 33542049 DOI: 10.1183/13993003.03380-2020 |
0.613 |
|
| 2021 |
Lin YC, Keenan K, Gong J, Panjwani N, Avolio J, Lin F, Adam D, Barrett P, Bégin S, Berthiaume Y, Bilodeau L, Bjornson C, Brusky J, Burgess C, Chilvers M, ... ... Ratjen F, et al. Cystic fibrosis-related diabetes onset can be predicted using biomarkers measured at birth. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 33500570 DOI: 10.1038/s41436-020-01073-x |
0.301 |
|
| 2021 |
Filipow N, Davies G, Main E, Sebire NJ, Wallis C, Ratjen F, Stanojevic S. Unsupervised Phenotypic Clustering for Determining Clinical Status in Children with Cystic Fibrosis. The European Respiratory Journal. PMID 33446607 DOI: 10.1183/13993003.02881-2020 |
0.373 |
|
| 2020 |
Bernasconi N, Kieninger E, Shaw M, Kurz J, Moeller A, Ratjen F, Rochat I, Stanojevic S, Singer F. CFTR-function and ventilation inhomogeneity in individuals with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 33349584 DOI: 10.1016/j.jcf.2020.12.009 |
0.387 |
|
| 2020 |
Munidasa S, Couch MJ, Rayment JH, Voskrebenzev A, Seethamraju R, Vogel-Claussen J, Ratjen F, Santyr G. Free-breathing MRI for Monitoring Ventilation Changes following Antibiotic Treatment of Pulmonary Exacerbations in Pediatric Cystic Fibrosis. The European Respiratory Journal. PMID 33303537 DOI: 10.1183/13993003.03104-2020 |
0.345 |
|
| 2020 |
Perrem L, Stanojevic S, Shaw M, Jensen R, McDonald N, Isaac SM, Davis M, Clem C, Guido J, Jara S, France L, Solomon M, Grasemann H, Waters V, Sweezey N, ... ... Ratjen F, et al. Lung Clearance Index to Track Acute Respiratory Events in School-age Children with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. PMID 33030967 DOI: 10.1164/rccm.202006-2433OC |
0.583 |
|
| 2020 |
Perrem L, Ratjen F. Designing Clinical Trials for Anti-Inflammatory Therapies in Cystic Fibrosis. Frontiers in Pharmacology. 11: 576293. PMID 33013419 DOI: 10.3389/Fphar.2020.576293 |
0.4 |
|
| 2020 |
Pollak M, Shaw M, Balkovec S, Wilson D, Kowalik K, Subbarao P, Ratjen F. Infant spirometry as a predictor of lung function at early childhood in cystic fibrosis patients. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 2116. PMID 32952083 DOI: 10.1016/J.Jcf.2020.09.005 |
0.453 |
|
| 2020 |
Eber E, Trawinska-Bartnicka M, Sands D, Bellon G, Mellies U, Bolbás K, Quattrucci S, Mazurek H, Widmann R, Schoergenhofer C, Jilma B, Ratjen F. Aerosolized lancovutide in adolescents (≥12 years) and adults with cystic fibrosis - a randomized trial. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 32888826 DOI: 10.1016/J.Jcf.2020.08.014 |
0.413 |
|
| 2020 |
Stanojevic S, Vukovojac K, Sykes J, Ratjen F, Tullis E, Stephenson AL. Projecting the impact of delayed access to elexacaftor/tezacaftor/ivacaftor for people with Cystic Fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 32855088 DOI: 10.1016/J.Jcf.2020.07.017 |
0.368 |
|
| 2020 |
Kilian A, Latino GA, White AJ, Clark D, Chakinala MM, Ratjen F, McDonald J, Whitehead K, Gossage JR, Lin D, Henderson K, Pollak J, McWilliams JP, Kim H, Lawton MT, et al. Genotype-Phenotype Correlations in Children with HHT. Journal of Clinical Medicine. 9. PMID 32842615 DOI: 10.3390/Jcm9092714 |
0.365 |
|
| 2020 |
Stanojevic S, Filipow N, Ratjen F. Paediatric reproducibility limits for the forced expiratory volume in 1 s. Thorax. PMID 32788261 DOI: 10.1136/Thoraxjnl-2020-214817 |
0.37 |
|
| 2020 |
Somayaji R, Yau YCW, Tullis E, LiPuma JJ, Ratjen F, Waters V. Clinical Outcomes Associated with Complex Infection in Patients with Cystic Fibrosis. Annals of the American Thoracic Society. PMID 32678679 DOI: 10.1513/Annalsats.202003-204Oc |
0.344 |
|
| 2020 |
Sagel SD, Khan U, Heltshe SL, Clancy JP, Borowitz D, Gelfond D, Donaldson SH, Moran A, Ratjen F, VanDalfsen JM, Rowe SM. Clinical Effectiveness of Lumacaftor/Ivacaftor in Cystic Fibrosis Patients Homozygous for F508del-CFTR. Annals of the American Thoracic Society. PMID 32644818 DOI: 10.1513/Annalsats.202002-144Oc |
0.465 |
|
| 2020 |
Muston HN, Perrem L, Davis MD, Ratjen F, Ren CL. The Remaining Barriers to Normalcy in CF: Advances in Assessment of CF Lung Disease. Pediatric Pulmonology. PMID 32589821 DOI: 10.1002/Ppul.24929 |
0.506 |
|
| 2020 |
Couch MJ, Munidasa S, Rayment JH, Voskrebenzev A, Seethamraju RT, Vogel-Claussen J, Ratjen F, Santyr G. Comparison of Functional Free-Breathing Pulmonary H and Hyperpolarized Xe Magnetic Resonance Imaging in Pediatric Cystic Fibrosis. Academic Radiology. PMID 32532639 DOI: 10.1016/J.Acra.2020.05.008 |
0.401 |
|
| 2020 |
Mayer-Hamblett N, van Koningsbruggen-Rietschel S, Nichols DP, VanDevanter DR, Davies JC, Lee T, Durmowicz AG, Ratjen F, Konstan MW, Pearson K, Bell SC, Clancy JP, Taylor-Cousar JL, De Boeck K, Donaldson SH, et al. Building global development strategies for cf therapeutics during a transitional cftr modulator era. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 32522463 DOI: 10.1016/J.Jcf.2020.05.011 |
0.392 |
|
| 2020 |
Waters V, Ratjen F. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. The Cochrane Database of Systematic Reviews. 6: CD010004. PMID 32521055 DOI: 10.1002/14651858.CD010004.pub5 |
0.356 |
|
| 2020 |
Shaw M, Khan U, Clancy JP, Donaldson SH, Sagel SD, Rowe SM, Ratjen F. Changes in LCI in F508del/F508del patients treated with lumacaftor/ivacaftor: Results from the prospect study. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 32513528 DOI: 10.1016/J.Jcf.2020.05.010 |
0.387 |
|
| 2020 |
Isaac SM, Jensen R, Anagnostopoulou P, Davies JC, Gappa M, Latzin P, Saunders C, Short C, Singer F, Stanojevic S, Zwitserloot A, Ratjen F. Evaluation of a multiple breath nitrogen washout system in children. Pediatric Pulmonology. PMID 32437013 DOI: 10.1002/Ppul.24862 |
0.375 |
|
| 2020 |
Skov L, Green K, Stanojevic S, Jensen R, Buchvald F, Ratjen F, Nielsen KG. Lung compartment analysis assessed from N multiple-breath washout in children with cystic fibrosis. Pediatric Pulmonology. PMID 32297698 DOI: 10.1002/Ppul.24773 |
0.484 |
|
| 2020 |
Pollak M, Shaw M, Wilson D, Grasemann H, Ratjen F. Bronchodilator Responsiveness in Children with Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis. The European Respiratory Journal. PMID 32269091 DOI: 10.1183/13993003.00175-2020 |
0.469 |
|
| 2020 |
Kowalik K, Dai R, Safavi S, Reyna ME, Lou W, Lepine C, McDonald E, Schaap M, Brydges MG, Dubeau A, Boutis K, Narang I, Eiwegger T, Moraes TJ, Ratjen F, et al. Persistent ventilation inhomogeneity after an acute exacerbation in preschool children with recurrent wheezing. Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology. PMID 32160369 DOI: 10.1111/Pai.13245 |
0.376 |
|
| 2020 |
Perrem L, Stanojevic S, Shaw M, Davis S, Retsch-Bogart G, Ratjen F. Changes in the parent cystic fibrosis questionnaire-revised (CFQ-R) with respiratory symptoms in preschool children with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 32139196 DOI: 10.1016/J.Jcf.2020.02.017 |
0.605 |
|
| 2020 |
Livingston MH, Mahant S, Connolly B, MacLusky I, Laberge S, Giglia L, Yang C, Roberts A, Shawyer A, Brindle M, Parsons S, Stoian C, Walton JM, Thorpe KE, Chen Y, ... ... Ratjen F, et al. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial. Jama Pediatrics. PMID 32011642 DOI: 10.1001/Jamapediatrics.2019.5863 |
0.333 |
|
| 2020 |
Shaw M, Oppelaar MC, Jensen R, Stanojevic S, Davis SD, Retsch-Bogart G, Ratjen FA. The utility of moment ratios and abbreviated endpoints of the multiple breath washout test in preschool children with cystic fibrosis. Pediatric Pulmonology. PMID 31899855 DOI: 10.1002/Ppul.24618 |
0.549 |
|
| 2020 |
Kowalik K, Dai R, Safavi S, Reyna ME, Lou W, Lepine C, McDonald E, Schaap M, Brydges MG, Dubeau A, Boutis K, Narang I, Eiwegger T, Moraes TJ, Ratjen F, et al. Author response for "Persistent ventilation inhomogeneity after an acute exacerbation in preschool children with recurrent wheezing" Applied Immunohistochemistry & Molecular Morphology. DOI: 10.1111/Pai.13245/V2/Response1 |
0.324 |
|
| 2019 |
Saunders C, Jensen R, Robinson PD, Stanojevic S, Klingel M, Short C, Davies JC, Ratjen F. Integrating the multiple breath washout test into international multicentre trials. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 31771900 DOI: 10.1016/J.Jcf.2019.11.006 |
0.426 |
|
| 2019 |
Couch MJ, Morgado F, Kanhere N, Kowalik K, Rayment JH, Ratjen F, Santyr G. Assessing the feasibility of hyperpolarized Xe multiple-breath washout MRI in pediatric cystic fibrosis. Magnetic Resonance in Medicine. PMID 31765507 DOI: 10.1002/Mrm.28099 |
0.389 |
|
| 2019 |
Perrem L, Ratjen F. Anti-inflammatories and mucociliary clearance therapies in the age of CFTR modulators. Pediatric Pulmonology. 54: S46-S55. PMID 31715088 DOI: 10.1002/Ppul.24364 |
0.491 |
|
| 2019 |
Zemanick E, Burgel PR, Taccetti G, Holmes A, Ratjen F, Byrnes CA, Waters VJ, Bell SC, VanDevanter DR, Stuart Elborn J, Flume PA. Antimicrobial resistance in cystic fibrosis: A Delphi approach to defining best practices. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 31680041 DOI: 10.1016/J.Jcf.2019.10.006 |
0.405 |
|
| 2019 |
Ooi CY, Sutherland R, Castellani C, Keenan K, Boland M, Reisman J, Bjornson C, Chilvers MA, van Wylick R, Kent S, Price A, Mateos-Corral D, Hughes D, Solomon M, Zuberbuhler P, ... ... Ratjen F, et al. Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis. Bmc Pediatrics. 19: 369. PMID 31640630 DOI: 10.1186/S12887-019-1756-4 |
0.416 |
|
| 2019 |
Grasemann H, Klingel M, Avolio J, Prentice C, Gonska T, Tullis E, Ratjen F. Long-term effect of CFTR modulator therapy on airway nitric oxide. The European Respiratory Journal. PMID 31601715 DOI: 10.1183/13993003.01113-2019 |
0.366 |
|
| 2019 |
Bell SC, Mall MA, Gutierrez H, Macek M, Madge S, Davies JC, Burgel PR, Tullis E, Castaños C, Castellani C, Byrnes CA, Cathcart F, Chotirmall SH, Cosgriff R, Eichler I, ... ... Ratjen F, et al. The future of cystic fibrosis care: a global perspective. The Lancet. Respiratory Medicine. PMID 31570318 DOI: 10.1016/S2213-2600(19)30337-6 |
0.432 |
|
| 2019 |
Ratjen F, Jensen R, Klingel M, McDonald R, Moore C, Benseler N, Wilson D, Stanojevic S. Effect of changes in tidal volume on multiple breath washout outcomes. Plos One. 14: e0219309. PMID 31269068 DOI: 10.1371/Journal.Pone.0219309 |
0.424 |
|
| 2019 |
Dong K, Singh A, Ng RT, Sin DD, Tebbutt SJ, Ratjen F, Quon BS. Proteomic Profiling to Identify Blood Biomarkers Predictive of Response to Azithromycin in Children and Adolescents with Cystic Fibrosis. Chest. PMID 31201785 DOI: 10.1016/J.Chest.2019.05.017 |
0.422 |
|
| 2019 |
Ratjen F, Davis SD, Stanojevic S, Kronmal RA, Hinckley Stukovsky KD, Jorgensen N, Rosenfeld M. Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial. The Lancet. Respiratory Medicine. PMID 31178421 DOI: 10.1016/S2213-2600(19)30187-0 |
0.661 |
|
| 2019 |
Singh A, He M, Chen V, Hollander Z, Tebbutt SJ, Ng RT, McManus BM, Sin DD, Ratjen F, Quon BS. Blood biomarkers to predict short-term pulmonary exacerbation risk in children and adolescents with CF: A pilot study. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 31176669 DOI: 10.1016/J.Jcf.2019.05.020 |
0.414 |
|
| 2019 |
Perrem L, Stanojevic S, Solomon M, Carpenter S, Ratjen F. Incidence and risk factors of paediatric cystic fibrosis-related diabetes. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 31072797 DOI: 10.1016/J.Jcf.2019.04.015 |
0.319 |
|
| 2019 |
Seidl E, Kiermeier H, Liebisch G, Ballmann M, Hesse S, Paul-Buck K, Ratjen F, Rietschel E, Griese M. Lavage lipidomics signatures in children with cystic fibrosis and protracted bacterial bronchitis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 31029606 DOI: 10.1016/J.Jcf.2019.04.012 |
0.438 |
|
| 2019 |
Couch MJ, Thomen R, Kanhere N, Hu R, Ratjen F, Woods J, Santyr G. A two-center analysis of hyperpolarized Xe lung MRI in stable pediatric cystic fibrosis: Potential as a biomarker for multi-site trials. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 30922812 DOI: 10.1016/J.Jcf.2019.03.005 |
0.461 |
|
| 2019 |
Klingel M, Stanojevic S, Tullis E, Ratjen F, Waters V. The Effect of Oral Azithromycin on the Response to Pulmonary Exacerbations Treated with Intravenous Tobramycin in Children with Cystic Fibrosis. Annals of the American Thoracic Society. PMID 30874447 DOI: 10.1513/Annalsats.201811-774Oc |
0.514 |
|
| 2019 |
Ratjen A, Au J, Carpenter S, John P, Ratjen F. Growth of Pulmonary Arteriovenous Malformations in Pediatric Patients with Hereditary Hemorrhagic Telangiectasia. The Journal of Pediatrics. PMID 30853205 DOI: 10.1016/J.Jpeds.2018.12.069 |
0.396 |
|
| 2019 |
Rayment JH, Couch MJ, McDonald N, Kanhere N, Manson D, Santyr G, Ratjen F. Hyperpolarised Xe MRI to monitor treatment response in children with cystic fibrosis. The European Respiratory Journal. PMID 30819815 DOI: 10.1183/13993003.02188-2018 |
0.519 |
|
| 2019 |
Perrem L, Stanojevic S, Klingel M, Isaac S, Jensen R, Solomon M, Grasemann H, Waters V, Sweezey N, Davis S, Ratjen F. Symptom duration and the lung clearance index in children with cystic fibrosis and pulmonary exacerbations European Respiratory Journal. DOI: 10.1183/13993003.Congress-2019.Pa330 |
0.644 |
|
| 2019 |
Stanojevic S, Filipow N, Ratjen F. Patient-specific FEV1 reproducibility limits to more accurately track disease progression European Respiratory Journal. DOI: 10.1183/13993003.Congress-2019.Oa1595 |
0.303 |
|
| 2018 |
Perrem L, Ratjen F. Letting It All Out: Neutrophils in Early CF Airway Inflammation. American Journal of Respiratory and Critical Care Medicine. PMID 30395720 DOI: 10.1164/Rccm.201810-1951Ed |
0.413 |
|
| 2018 |
Hebestreit H, Hulzebos EH, Schneiderman JE, Karila C, Boas SR, Kriemler S, Dwyer T, Sahlberg M, Urquhart DS, Lands LC, Ratjen F, Takken T, Varanistkaya L, Rücker V, Hebestreit A, et al. Cardiopulmonary exercise testing provides additional prognostic information in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. PMID 30321487 DOI: 10.1164/Rccm.201806-1110Oc |
0.336 |
|
| 2018 |
Perrem L, Rayment JH, Ratjen F. The lung clearance index as a monitoring tool in cystic fibrosis: ready for the clinic? Current Opinion in Pulmonary Medicine. PMID 30095491 DOI: 10.1097/Mcp.0000000000000515 |
0.459 |
|
| 2018 |
Perrem L, Rayment JH, Ratjen F. The lung clearance index as a monitoring tool in cystic fibrosis: ready for the clinic? Current Opinion in Pulmonary Medicine. PMID 30095491 DOI: 10.1097/MCP.0000000000000515 |
0.354 |
|
| 2018 |
Santyr G, Kanhere N, Morgado F, Rayment JH, Ratjen F, Couch MJ. Hyperpolarized Gas Magnetic Resonance Imaging of Pediatric Cystic Fibrosis Lung Disease. Academic Radiology. PMID 30087066 DOI: 10.1016/J.Acra.2018.04.024 |
0.46 |
|
| 2018 |
Santyr G, Kanhere N, Morgado F, Rayment JH, Ratjen F, Couch MJ. Hyperpolarized Gas Magnetic Resonance Imaging of Pediatric Cystic Fibrosis Lung Disease. Academic Radiology. PMID 30087066 DOI: 10.1016/j.acra.2018.04.024 |
0.354 |
|
| 2018 |
Lu Z, Foong RE, Kowalik K, Moraes TJ, Boyce A, Dubeau A, Balkovec S, Gustafsson PM, Becker AB, Mandhane PJ, Turvey SE, Lou W, Ratjen F, Sears M, Subbarao P. Ventilation inhomogeneity in infants with recurrent wheezing. Thorax. PMID 29907664 DOI: 10.1136/Thoraxjnl-2017-211351 |
0.396 |
|
| 2018 |
Lu Z, Foong RE, Kowalik K, Moraes TJ, Dubeau A, Lefebvre D, Davis SD, Balkovec S, Becker A, Mandhane P, Turvey SE, Lou W, Sears MR, Ratjen F, Subbarao P. Reference equations for the interpretation of forced expiratory and plethysmographic measurements in infants. Pediatric Pulmonology. PMID 29790670 DOI: 10.1002/Ppul.24063 |
0.548 |
|
| 2018 |
Ratjen F, Moeller A, McKinney ML, Asherova I, Alon N, Maykut R, Angyalosi G. Eradication of early P. aeruginosa infection in children <7 years of age with cystic fibrosis: The early study. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 29685813 DOI: 10.1016/J.Jcf.2018.04.002 |
0.445 |
|
| 2018 |
Eckford PDW, McCormack J, Munsie L, He G, Stanojevic S, Pereira SL, Ho K, Avolio J, Bartlett C, Yang JY, Wong AP, Wellhauser L, Huan LJ, Jiang JX, Ouyang H, ... ... Ratjen F, et al. The CF Canada-Sick Kids Program in individual CF therapy: A resource for the advancement of personalized medicine in CF. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 29685812 DOI: 10.1016/J.Jcf.2018.03.013 |
0.387 |
|
| 2018 |
Ratjen F, Klingel M, Black P, Powers MR, Grasemann H, Solomon M, Sagel SD, Donaldson SH, Rowe SM, Rosenfeld M. Changes in Lung Clearance Index in Preschool Cystic Fibrosis Patients Treated with Ivacaftor. American Journal of Respiratory and Critical Care Medicine. PMID 29614238 DOI: 10.1164/Rccm.201802-0243Le |
0.478 |
|
| 2018 |
Blanchard AC, Rooney AM, Yau Y, Zhang Y, Stapleton PJ, Horton E, Klingel M, Stanojevic S, Ratjen F, Coburn B, Waters V. Early detection using qPCR of Pseudomonas aeruginosa infection in children with cystic fibrosis undergoing eradication treatment. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 29525410 DOI: 10.1016/J.Jcf.2018.02.008 |
0.38 |
|
| 2018 |
Castellani C, Duff AJA, Bell SC, Heijerman HGM, Munck A, Ratjen F, Sermet-Gaudelus I, Southern KW, Barben J, Flume PA, Hodková P, Kashirskaya N, Kirszenbaum MN, Madge S, Oxley H, et al. ECFS best practice guidelines: the 2018 revision. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 29506920 DOI: 10.1016/J.Jcf.2018.02.006 |
0.412 |
|
| 2018 |
Robinson PD, Latzin P, Ramsey KA, Stanojevic S, Aurora P, Davis SD, Gappa M, Hall GL, Horsley A, Jensen R, Lum S, Milla C, Nielsen KG, Pittman JE, Rosenfeld M, ... ... Ratjen F, et al. Preschool Multiple-Breath Washout Testing. An Official American Thoracic Society Technical Statement. American Journal of Respiratory and Critical Care Medicine. 197: e1-e19. PMID 29493315 DOI: 10.1164/Rccm.201801-0074St |
0.588 |
|
| 2018 |
Rayment JH, Stanojevic S, Davis SD, Retsch-Bogart G, Ratjen F. Lung clearance index to monitor treatment response in pulmonary exacerbations in preschool children with cystic fibrosis. Thorax. PMID 29449440 DOI: 10.1136/Thoraxjnl-2017-210979 |
0.672 |
|
| 2018 |
Klingel M, Isaac S, Stanojevic S, Jensen R, Solomon M, Grasemann H, Waters V, Sweezey N, Davis S, Ratjen F. Does the lung clearance index track from preschool to school age in children with cystic fibrosis European Respiratory Journal. DOI: 10.1183/13993003.Congress-2018.Pa4624 |
0.604 |
|
| 2018 |
Au JWY, Mcdonald R, Stanojevic S, Ratjen F. The effect of spirometry on multiple breath washout outcomes in children with cystic fibrosis European Respiratory Journal. 52. DOI: 10.1183/13993003.Congress-2018.Pa4623 |
0.445 |
|
| 2018 |
McDonald R, Stanojevic S, Jensen R, Ratjen F. Do deviations in tidal breathing impact multiple breath washout measurements European Respiratory Journal. 52. DOI: 10.1183/13993003.Congress-2018.Oa4987 |
0.33 |
|
| 2018 |
Perrem L, Ratjen F, Dell S, Wilson D. Development and pilot evaluation of a quality grading system for paediatric spirometry European Respiratory Journal. 52. DOI: 10.1183/13993003.Congress-2018.Oa3774 |
0.324 |
|
| 2018 |
Taylor-Cousar JL, Tullis E, Derichs N, Davies JC, Nazareth D, Downey D, Rosenbluth D, Fajac I, Malfroot A, Saunders C, Short C, Jensen R, Solomon GM, Vermeulen F, Willmann S, ... ... Ratjen F, et al. P028 Riociguat for the treatment of adult Phe508del homozygous cystic fibrosis: efficacy data from the Phase II Rio-CF study Journal of Cystic Fibrosis. 17. DOI: 10.1016/S1569-1993(18)30325-4 |
0.369 |
|
| 2017 |
Fernandopulle N, Mertens L, Klingel M, Manson D, Ratjen F. Echocardiography Grading for Pulmonary Arteriovenous Malformation Screening in Children with Hereditary Hemorrhagic Telangiectasia. The Journal of Pediatrics. PMID 29274888 DOI: 10.1016/J.Jpeds.2017.11.047 |
0.382 |
|
| 2017 |
Radtke T, Hebestreit H, Gallati S, Schneiderman JE, Braun J, Stevens D, Hulzebos EH, Takken T, Boas SR, Urquhart DS, Lands LC, Tejero S, Sovtic A, Dwyer T, Petrovic M, ... ... Ratjen F, et al. CFTR Genotype and Maximal Exercise Capacity in Cystic Fibrosis: A Cross-sectional Study. Annals of the American Thoracic Society. PMID 29140739 DOI: 10.1513/Annalsats.201707-570Oc |
0.356 |
|
| 2017 |
Ramsey K, Ratjen F, Latzin P. Elucidating progression of early cystic fibrosis lung disease. The European Respiratory Journal. 50. PMID 29122922 DOI: 10.1183/13993003.01916-2017 |
0.481 |
|
| 2017 |
Hayeems RZ, Miller FA, Vermeulen M, Potter BK, Chakraborty P, Davies C, Carroll JC, Ratjen F, Guttmann A. False-Positive Newborn Screening for Cystic Fibrosis and Health Care Use. Pediatrics. PMID 29025964 DOI: 10.1542/Peds.2017-0604 |
0.325 |
|
| 2017 |
Oude Engberink E, Ratjen F, Davis SD, Retsch-Bogart G, Amin R, Stanojevic S. Inter-test reproducibility of the lung clearance index measured by multiple breath washout. The European Respiratory Journal. 50. PMID 28982773 DOI: 10.1183/13993003.00433-2017 |
0.575 |
|
| 2017 |
Waters V, Ratjen F. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. The Cochrane Database of Systematic Reviews. 10: CD009528. PMID 28981972 DOI: 10.1002/14651858.Cd009528.Pub4 |
0.41 |
|
| 2017 |
Rayment JH, Ratjen F. Another Brick in the Wall: Lung Clearance Index and Lower Airways Pathology in Preschool Cystic Fibrosis. Annals of the American Thoracic Society. 14: 1389-1390. PMID 28862497 DOI: 10.1513/Annalsats.201706-432Ed |
0.48 |
|
| 2017 |
Grasemann H, Ciet P, Amin R, McDonald N, Klingel M, Tiddens HAWM, Ratjen F, Grosse-Wortmann L. Changes in magnetic resonance imaging scores and ventilation inhomogeneity in children with cystic fibrosis pulmonary exacerbations. The European Respiratory Journal. 50. PMID 28838978 DOI: 10.1183/13993003.00244-2017 |
0.463 |
|
| 2017 |
Molinski SV, Ahmadi S, Ip W, Ouyang H, Villella A, Miller JP, Lee PS, Kulleperuma K, Du K, Di Paola M, Eckford PD, Laselva O, Huan LJ, Wellhauser L, Li E, ... ... Ratjen F, et al. Orkambi® and amplifier co-therapy improves function from a rare CFTR mutation in gene-edited cells and patient tissue. Embo Molecular Medicine. PMID 28667089 DOI: 10.15252/Emmm.201607137 |
0.324 |
|
| 2017 |
Ahmadi S, Bozoky Z, Di Paola M, Xia S, Li C, Wong AP, Wellhauser L, Molinski SV, Ip W, Ouyang H, Avolio J, Forman-Kay JD, Ratjen F, Hirota JA, Rommens J, et al. Phenotypic profiling of CFTR modulators in patient-derived respiratory epithelia. Npj Genomic Medicine. 2: 12. PMID 28649446 DOI: 10.1038/S41525-017-0015-6 |
0.407 |
|
| 2017 |
Livingston MH, Mahant S, Ratjen F, Connolly BL, Thorpe K, Mamdani M, Maclusky I, Laberge S, Giglia L, Walton JM, Yang CL, Roberts A, Shawyer AC, Brindle M, Parsons SJ, et al. Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial. Trials. 18: 293. PMID 28646887 DOI: 10.1186/S13063-017-2026-0 |
0.317 |
|
| 2017 |
Waters V, Ratjen F. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis. The Cochrane Database of Systematic Reviews. 6: CD006961. PMID 28628280 DOI: 10.1002/14651858.Cd006961.Pub4 |
0.368 |
|
| 2017 |
Ratjen F, Hug C, Marigowda G, Tian S, Huang X, Stanojevic S, Milla CE, Robinson PD, Waltz D, Davies JC. Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial. The Lancet. Respiratory Medicine. PMID 28606620 DOI: 10.1016/S2213-2600(17)30215-1 |
0.412 |
|
| 2017 |
Somayaji R, Stanojevic S, Tullis DE, Stephenson AL, Ratjen F, Waters V. Clinical Outcomes Associated with Achromobacter Species Infection in Patients with Cystic Fibrosis. Annals of the American Thoracic Society. PMID 28406714 DOI: 10.1513/Annalsats.201701-071Oc |
0.385 |
|
| 2017 |
Hayeems RZ, Miller FA, Barg CJ, Bombard Y, Carroll JC, Tam K, Kerr E, Chakraborty P, Potter BK, Patton S, Bytautas JP, Taylor L, Davies C, Milburn J, Price A, ... ... Ratjen F, et al. Psychosocial Response to Uncertain Newborn Screening Results for Cystic Fibrosis. The Journal of Pediatrics. PMID 28279431 DOI: 10.1016/J.Jpeds.2017.01.049 |
0.401 |
|
| 2017 |
Waters V, Yau Y, Beaudoin T, Wettlaufer J, Tom SK, McDonald N, Rizvi L, Klingel M, Ratjen F, Tullis E. Pilot trial of tobramycin inhalation powder in cystic fibrosis patients with chronic Burkholderia cepacia complex infection. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 28262569 DOI: 10.1016/J.Jcf.2017.02.008 |
0.403 |
|
| 2017 |
Blanchard AC, Horton E, Stanojevic S, Taylor L, Waters V, Ratjen F. Effectiveness of a stepwise Pseudomonas aeruginosa eradication protocol in children with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 28189634 DOI: 10.1016/J.Jcf.2017.01.007 |
0.45 |
|
| 2017 |
Ratjen F. How Best to Capture Early Cystic Fibrosis Lung Disease? American Journal of Respiratory and Critical Care Medicine. 195: 283-284. PMID 28145764 DOI: 10.1164/Rccm.201609-1836Ed |
0.467 |
|
| 2017 |
Subbarao P, Milla CE, Morgan WJ, Ratjen F. Corrections to an ATS Workshop Report on Multiple-Breath Washout Testing for Patients with Cystic Fibrosis. Annals of the American Thoracic Society. 14: 145. PMID 28035881 DOI: 10.1513/Annalsats.201610-796Le |
0.408 |
|
| 2017 |
Klingel M, Stanojevic S, Jensen R, Rosenfeld M, Davis S, Ratjen F, Retsch-Bogart G. Effect of reporting two versus three trials on lung clearance index values European Respiratory Journal. DOI: 10.1183/1393003.Congress-2017.Oa1792 |
0.565 |
|
| 2017 |
Brody A, Nagle S, Hug C, Marigowda G, Waltz D, Goldin J, Ratjen F, Wang L. S93 Effect of lumacaftor/ivacaftor on total, bronchiectasis, and air trapping computed tomography (ct) scores in children homozygous for f508del-cftr: exploratory imaging substudy Thorax. 72. DOI: 10.1136/Thoraxjnl-2017-210983.99 |
0.397 |
|
| 2017 |
Nagle S, Brody A, Woods J, Johnson K, Wang L, Marigowda G, Waltz D, Goldin J, Ratjen F, Hug C. P254 Feasibility of ultrashort echo time (ute) mri to evaluate the effect of lumacaftor/ivacaftor therapy in children with cystic fibrosis (cf) homozygous for f508del Thorax. 72. DOI: 10.1136/Thoraxjnl-2017-210983.396 |
0.34 |
|
| 2017 |
Derichs N, Taylor-Cousar J, Tullis E, Davies J, Nazareth D, Downey DG, Rosenbluth D, Fajac I, Malfroot A, Bakker M, Clancy JP, Uluer A, Castellani C, Sermet-Gaudelus I, Ahrens RC, ... ... Ratjen F, et al. EPS1.3 Safety, tolerability and early signs of efficacy with riociguat for the treatment of adult Phe508del homozygous cystic fibrosis patients: study design and rationale for the Rio-CF study Journal of Cystic Fibrosis. 16. DOI: 10.1016/S1569-1993(17)30276-X |
0.391 |
|
| 2016 |
Strug LJ, Gonska T, He G, Keenan K, Ip W, Boëlle PY, Lin F, Panjwani N, Gong J, Li W, Soave D, Xiao B, Tullis E, Rabin H, Parkins MD, ... ... Ratjen F, et al. Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics. Human Molecular Genetics. 25: 4590-4600. PMID 28171547 DOI: 10.1093/Hmg/Ddw290 |
0.44 |
|
| 2016 |
Waters V, Ratjen F. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. The Cochrane Database of Systematic Reviews. 12: CD010004. PMID 28000919 DOI: 10.1002/14651858.Cd010004.Pub4 |
0.461 |
|
| 2016 |
Stanojevic S, Davis SD, Retsch-Bogart G, Webster H, Davis M, Johnson RC, Jensen R, Pizarro ME, Kane M, Clem CC, Schornick L, Subbarao P, Ratjen FA. Progression of Lung Disease in Preschool Patients with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. PMID 27943680 DOI: 10.1164/Rccm.201610-2158Oc |
0.589 |
|
| 2016 |
Oude Engberink E, Stanojevic S, Ratjen F. Clinimetric Properties of the Lung Clearance Index in Adults and Children With Cystic Fibrosis. Chest. 150: 1412-1413. PMID 27938756 DOI: 10.1016/J.Chest.2016.08.1478 |
0.466 |
|
| 2016 |
Rayment JH, Ratjen F. Constrictive Bronchiolitis: A Distinct Phenotype of Cystic Fibrosis Lung Disease? Annals of the American Thoracic Society. 13: 2111-2112. PMID 27925783 DOI: 10.1513/Annalsats.201609-701Ed |
0.464 |
|
| 2016 |
Milla CE, Ratjen F, Marigowda G, Liu F, Waltz D, Rosenfeld M. Lumacaftor/Ivacaftor in Patients Aged 6-11 Years With Cystic Fibrosis Homozygous for F508del-CFTR. American Journal of Respiratory and Critical Care Medicine. PMID 27805836 DOI: 10.1164/Rccm.201608-1754Oc |
0.448 |
|
| 2016 |
Waters V, Stanojevic S, Ratjen F. Special considerations for the treatment of pulmonary exacerbations in children with cystic fibrosis. Expert Review of Respiratory Medicine. PMID 27718754 DOI: 10.1080/17476348.2017.1246963 |
0.547 |
|
| 2016 |
Bombard Y, Miller FA, Barg CJ, Patton SJ, Carroll JC, Chakraborty P, Potter BK, Tam K, Taylor L, Kerr E, Davies C, Milburn J, Ratjen F, Guttmann A, Hayeems RZ. A secondary benefit: the reproductive impact of carrier results from newborn screening for cystic fibrosis. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 27608173 DOI: 10.1038/Gim.2016.125 |
0.395 |
|
| 2016 |
Strug LJ, Gonska T, He G, Keenan K, Ip W, Boelle PY, Lin F, Panjwani N, Gong J, Li W, Soave D, Xiao B, Tullis E, Rabin H, Parkins MD, ... ... Ratjen F, et al. Cystic Fibrosis Gene Modifier SLC26A9 Modulates Airway Response to CFTR-directed Therapeutics. Human Molecular Genetics. PMID 27571897 DOI: 10.1093/hmg/ddw290 |
0.331 |
|
| 2016 |
Stanojevic S, McDonald A, Waters V, MacDonald S, Horton E, Tullis E, Ratjen F. Effect of pulmonary exacerbations treated with oral antibiotics on clinical outcomes in cystic fibrosis. Thorax. PMID 27539619 DOI: 10.1136/Thoraxjnl-2016-208450 |
0.459 |
|
| 2016 |
Hayeems RZ, Miller FA, Barg CJ, Bombard Y, Kerr E, Tam K, Carroll JC, Potter BK, Chakraborty P, Davies C, Milburn J, Patton S, Bytautas JP, Taylor L, Price A, ... ... Ratjen F, et al. Parent Experience With False-Positive Newborn Screening Results for Cystic Fibrosis. Pediatrics. PMID 27485696 DOI: 10.1542/Peds.2016-1052 |
0.359 |
|
| 2016 |
Wettlaufer J, Klingel M, Yau Y, Stanojevic S, Tullis E, Ratjen F, Waters V. Longitudinal study of Stenotrophomonas maltophilia antibody levels and outcomes in cystic fibrosis patients. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 27346471 DOI: 10.1016/J.Jcf.2016.06.007 |
0.396 |
|
| 2016 |
Stanojevic S, Ratjen F. Physiologic endpoints for clinical studies for cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 27316663 DOI: 10.1016/J.Jcf.2016.05.014 |
0.484 |
|
| 2016 |
Ratjen F. Pulmonary artery hypertension: an underrated disease manifestation in cystic fibrosis? The Lancet. Respiratory Medicine. PMID 27298018 DOI: 10.1016/S2213-2600(16)30107-2 |
0.389 |
|
| 2016 |
Inarejos Clemente EJ, Ratjen F, Manson DE. Utility of MDCT MIP Postprocessing Reconstruction Images in Children With Hereditary Hemorrhagic Telangiectasia. Journal of Computer Assisted Tomography. PMID 26953767 DOI: 10.1097/Rct.0000000000000385 |
0.334 |
|
| 2016 |
Kane M, Gonska T, Jensen R, Avolio J, Klingel M, Stanojevic S, Ratjen F. Lung clearance index response in patients with CF with class III CFTR mutations. Thorax. PMID 26944510 DOI: 10.1136/Thoraxjnl-2015-207894 |
0.513 |
|
| 2016 |
Amin R, Stanojevic S, Kane M, Webster H, Ratjen F. A randomized controlled trial to evaluate the lung clearance index as an outcome measure for early phase studies in patients with cystic fibrosis. Respiratory Medicine. PMID 26856191 DOI: 10.1016/J.Rmed.2016.01.020 |
0.455 |
|
| 2016 |
Côté M, Boulay M, Plante S, Chakir J, Boulet L, Ahmed H, Ospina M, Sideri K, Vliagoftis H, Johnson SF, Woodgate RL, Cros G, Teira P, Cellot S, Bittencourt H, ... ... Ratjen F, et al. Proceedings of the Canadian society of allergy and clinical immunology annual scientific meeting 2015 Allergy, Asthma & Clinical Immunology. 12: 22. DOI: 10.1186/S13223-016-0118-0 |
0.306 |
|
| 2016 |
Anagnostopoulou P, Jensen R, Kranz N, Yammine S, Latzin P, Ratjen F. New reference values for N2multiple breath washout outcomes in pre-school and school-aged children European Respiratory Journal. 48. DOI: 10.1183/13993003.Congress-2016.Pa371 |
0.353 |
|
| 2016 |
Radtke T, Hebestreit H, Gallati S, Schneiderman JE, Stevens D, Hulzebos EHJ, Takken T, Boas SR, Urquhart DS, Lands LC, Tejero S, Sovtic A, Ratjen F, Kriemler S. LATE-BREAKING ABSTRACT: Aerobic exercise capacity in cystic fibrosis – Does CFTR genotype matter? European Respiratory Journal. 48. DOI: 10.1183/13993003.Congress-2016.Pa1268 |
0.422 |
|
| 2016 |
Stanojevic S, Jensen R, Webser H, Kane M, Pizarro ME, Davis S, Retsch-Bogart G, Subbarao P, Ratjen F. Tracking pulmonary exacerbations in preschool children using the lung clearance index European Respiratory Journal. 48. DOI: 10.1183/13993003.Congress-2016.Oa1490 |
0.65 |
|
| 2016 |
McColley SA, Davies J, Ratjen F, Jain M. New insights into disease progression for the CFTR modulator-treated cystic fibrosis patient Journal of Cystic Fibrosis. DOI: 10.1016/J.Jcf.2015.12.014 |
0.395 |
|
| 2015 |
Ratjen F, Bell SC, Rowe SM, Goss CH, Quittner AL, Bush A. Cystic fibrosis. Nature Reviews. Disease Primers. 1: 15010. PMID 27189798 DOI: 10.1038/nrdp.2015.10 |
0.316 |
|
| 2015 |
Waters V, Ratjen F. Pulmonary Exacerbations in Children with Cystic Fibrosis. Annals of the American Thoracic Society. 12: S200-6. PMID 26595740 DOI: 10.1513/Annalsats.201502-098Aw |
0.509 |
|
| 2015 |
Ratjen F, Waters V, Klingel M, McDonald N, Dell S, Leahy TR, Yau Y, Grasemann H. Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia. The European Respiratory Journal. PMID 26585432 DOI: 10.1183/13993003.01390-2015 |
0.513 |
|
| 2015 |
Davis SD, Ratjen F, Brumback LC, Johnson RC, Filbrun AG, Kerby GS, Panitch HB, Donaldson SH, Rosenfeld M. Infant lung function tests as endpoints in the ISIS multicenter clinical trial in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 26547590 DOI: 10.1016/J.Jcf.2015.10.007 |
0.585 |
|
| 2015 |
Ooi CY, Ratjen F, Gonska T. Author's Response: Re: Stratifying Cystic Fibrosis Risk for Newborn Screen Infants With Equivocal Sweat Chloride Levels. Pediatrics. 136: e1490-1. PMID 26527092 DOI: 10.1542/Peds.2015-2786B |
0.364 |
|
| 2015 |
Subbarao P, Lu Z, Kowalik K, Brown M, Balkovec S, Gustafsson P, Lou W, Ratjen F. Changes in multiple breath washout measures after raised volume rapid thoracoabdominal compression maneuvers in infants. Pediatric Pulmonology. PMID 26383784 DOI: 10.1002/Ppul.23220 |
0.403 |
|
| 2015 |
Gonska T, Ratjen F. Newborn screening for cystic fibrosis. Expert Review of Respiratory Medicine. 9: 619-31. PMID 26366807 DOI: 10.1586/17476348.2015.1085804 |
0.407 |
|
| 2015 |
Waters V, Stanojevic S, Klingel M, Chiang J, Sonneveld N, Kukkar R, Tullis E, Ratjen F. Prolongation of antibiotic treatment for cystic fibrosis pulmonary exacerbations. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 26265220 DOI: 10.1016/J.Jcf.2015.07.010 |
0.52 |
|
| 2015 |
Grasemann H, Gonska T, Avolio J, Klingel M, Tullis E, Ratjen F. Effect of ivacaftor therapy on exhaled nitric oxide in patients with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 26168933 DOI: 10.1016/J.Jcf.2015.07.001 |
0.455 |
|
| 2015 |
Sonneveld N, Stanojevic S, Amin R, Aurora P, Davies J, Elborn JS, Horsley A, Latzin P, O'Neill K, Robinson P, Scrase E, Selvadurai H, Subbarao P, Welsh L, Yammine S, ... Ratjen F, et al. Lung clearance index in cystic fibrosis subjects treated for pulmonary exacerbations. The European Respiratory Journal. PMID 26160868 DOI: 10.1183/09031936.00211914 |
0.496 |
|
| 2015 |
Torphy TJ, Allen J, Cantin AM, Konstan MW, Accurso FJ, Joseloff E, Ratjen FA, Chmiel JF. Considerations for the Conduct of Clinical Trials with Anti-inflammatory Agents in Cystic Fibrosis: A Cystic Fibrosis Foundation Workshop Report. Annals of the American Thoracic Society. PMID 26146892 DOI: 10.1513/Annalsats.201506-361Ot |
0.358 |
|
| 2015 |
Subbarao P, Milla C, Aurora P, Davies JC, Davis SD, Hall GL, Heltshe S, Latzin P, Lindblad A, Pittman JE, Robinson PD, Rosenfeld M, Singer F, Starner TD, Ratjen F, et al. Multiple-Breath Washout as a Lung Function Test in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop Report. Annals of the American Thoracic Society. 12: 932-9. PMID 26075554 DOI: 10.1513/Annalsats.201501-021Fr |
0.658 |
|
| 2015 |
Wainwright CE, Elborn JS, Ramsey BW, Marigowda G, Huang X, Cipolli M, Colombo C, Davies JC, De Boeck K, Flume PA, Konstan MW, McColley SA, McCoy K, McKone EF, Munck A, ... Ratjen F, et al. Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. The New England Journal of Medicine. 373: 220-31. PMID 25981758 DOI: 10.1056/Nejmoa1409547 |
0.439 |
|
| 2015 |
Ooi CY, Castellani C, Keenan K, Avolio J, Volpi S, Boland M, Kovesi T, Bjornson C, Chilvers MA, Morgan L, van Wylick R, Kent S, Price A, Solomon M, Tam K, ... ... Ratjen F, et al. Inconclusive diagnosis of cystic fibrosis after newborn screening. Pediatrics. 135: e1377-85. PMID 25963003 DOI: 10.1542/Peds.2014-2081 |
0.391 |
|
| 2015 |
Ratjen F, Koker P, Geller DE, Langellier-Cocteaux B, Le Maulf F, Kattenbeck S, Moroni-Zentgraf P, Elborn JS. Tiotropium Respimat® in cystic fibrosis: Phase 3 and Pooled phase 2/3 randomized trials. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 25819269 DOI: 10.1016/J.Jcf.2015.03.004 |
0.355 |
|
| 2015 |
Waters VJ, Stanojevic S, Sonneveld N, Klingel M, Grasemann H, Yau YC, Tullis E, Wilcox P, Freitag A, Chilvers M, Ratjen FA. Factors associated with response to treatment of pulmonary exacerbations in cystic fibrosis patients. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. PMID 25690407 DOI: 10.1016/j.jcf.2015.01.007 |
0.396 |
|
| 2015 |
Stanojevic S, Jensen R, Sundaralingam D, Salazar JG, Yammine S, Singer F, Latzin P, Amin R, Subbarao P, Gustafsson P, Ratjen F. Alternative outcomes for the multiple breath washout in children with CF. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 14: 490-6. PMID 25578856 DOI: 10.1016/J.Jcf.2014.12.008 |
0.477 |
|
| 2015 |
Yau YC, Ratjen F, Tullis E, Wilcox P, Freitag A, Chilvers M, Grasemann H, Zlosnik J, Speert D, Corey M, Stanojevic S, Matukas L, Leahy TR, Shih S, Waters V. Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 14: 262-6. PMID 25453872 DOI: 10.1016/J.Jcf.2014.09.013 |
0.443 |
|
| 2015 |
Alpern AN, Brumback LC, Ratjen F, Rosenfeld M, Davis SD, Quittner AL. Initial evaluation of the Parent Cystic Fibrosis Questionnaire--Revised (CFQ-R) in infants and young children. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 14: 403-11. PMID 25443473 DOI: 10.1016/J.Jcf.2014.11.002 |
0.595 |
|
| 2015 |
Bin-Hasan S, Ratjen F. Tiotropium bromide for cystic fibrosis Expert Opinion On Orphan Drugs. 3: 957-966. DOI: 10.1517/21678707.2015.1065728 |
0.479 |
|
| 2015 |
Jensen R, Stanojevic S, Pizarro ME, Klingel M, Ratjen F. Inter-reviewer agreement of a standardized MBW quality control tool European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Pa4152 |
0.356 |
|
| 2015 |
Jensen R, Stanojevic S, Klingel M, Ratjen F. A standardized tool to assess quality of MBW tracings European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Pa4146 |
0.389 |
|
| 2015 |
Sonneveld N, Stanojevic S, Jensen R, Subbarao P, Ratjen F. Does the lung clearance index track with disease progression in early childhood European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Pa2049 |
0.475 |
|
| 2015 |
Kowalik K, Lu Z, Lou W, Balkovec S, Lau F, Gustafsson P, Sears MR, Ratjen F, Subbarao P. Feasibility of performing pulmonary function testing in cohort studies European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Pa1270 |
0.377 |
|
| 2015 |
Raaijmakers L, Jensen R, Stanojevic S, Merkus P, Ratjen F. In vitro and in vivo comparison of two multiple breath nitrogen washout devices European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Pa1262 |
0.331 |
|
| 2015 |
Grasemann H, Gonska T, Avolio J, Klingel M, Tullis E, Ratjen F. Airway nitric oxide production in patients with cystic fibrosis increases with ivacaftor therapy European Respiratory Journal. 46. DOI: 10.1183/13993003.Congress-2015.Oa1444 |
0.514 |
|
| 2015 |
Grasemann H, Gonska T, Avolio J, Tullis E, Ratjen F. 144 Effect of treatment with ivacaftor on exhaled nitric oxide Journal of Cystic Fibrosis. 14. DOI: 10.1016/S1569-1993(15)30321-0 |
0.476 |
|
| 2014 |
Tiddens HA, Puderbach M, Venegas JG, Ratjen F, Donaldson SH, Davis SD, Rowe SM, Sagel SD, Higgins M, Waltz DA. Novel outcome measures for clinical trials in cystic fibrosis. Pediatric Pulmonology. PMID 25641878 DOI: 10.1002/Ppul.23146 |
0.593 |
|
| 2014 |
Mogayzel PJ, Naureckas ET, Robinson KA, Brady C, Guill M, Lahiri T, Lubsch L, Matsui J, Oermann CM, Ratjen F, Rosenfeld M, Simon RH, Hazle L, Sabadosa K, Marshall BC, et al. Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection. Annals of the American Thoracic Society. 11: 1640-50. PMID 25549030 DOI: 10.1513/Annalsats.201404-166Oc |
0.435 |
|
| 2014 |
Waters V, Ratjen F. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. The Cochrane Database of Systematic Reviews. 12: CD010004. PMID 25470304 DOI: 10.1002/14651858.CD010004.pub3 |
0.366 |
|
| 2014 |
McKone EF, Borowitz D, Drevinek P, Griese M, Konstan MW, Wainwright C, Ratjen F, Sermet-Gaudelus I, Plant B, Munck A, Jiang Y, Gilmartin G, Davies JC. Long-term safety and efficacy of ivacaftor in patients with cystic fibrosis who have the Gly551Asp-CFTR mutation: a phase 3, open-label extension study (PERSIST). The Lancet. Respiratory Medicine. 2: 902-10. PMID 25311995 DOI: 10.1016/S2213-2600(14)70218-8 |
0.426 |
|
| 2014 |
Bradley JM, Koker P, Deng Q, Moroni-Zentgraf P, Ratjen F, Geller DE, Elborn JS. Testing two different doses of tiotropium Respimat® in cystic fibrosis: phase 2 randomized trial results. Plos One. 9: e106195. PMID 25188297 DOI: 10.1371/Journal.Pone.0106195 |
0.418 |
|
| 2014 |
Grasemann H, Jaecklin T, Mehl A, Huang H, Rafii M, Pencharz P, Ratjen F. Multitracer stable isotope quantification of arginase and nitric oxide synthase activity in a mouse model of pseudomonas lung infection. Mediators of Inflammation. 2014: 323526. PMID 25177109 DOI: 10.1155/2014/323526 |
0.376 |
|
| 2014 |
Chmiel JF, Aksamit TR, Chotirmall SH, Dasenbrook EC, Elborn JS, LiPuma JJ, Ranganathan SC, Waters VJ, Ratjen FA. Antibiotic management of lung infections in cystic fibrosis. II. Nontuberculous mycobacteria, anaerobic bacteria, and fungi. Annals of the American Thoracic Society. 11: 1298-306. PMID 25167882 DOI: 10.1513/AnnalsATS.201405-203AS |
0.349 |
|
| 2014 |
Sharma A, Geller DE, Moroni-Zentgraf P, Kattenbeck S, Schmid M, Boland K, Rapp B, Konstan MW, Ratjen F, Elborn JS, Koker P. Pooled analysis of tiotropium Respimat(®) pharmacokinetics in cystic fibrosis. Pulmonary Pharmacology & Therapeutics. 29: 217-23. PMID 25161072 DOI: 10.1016/j.pupt.2014.08.004 |
0.354 |
|
| 2014 |
Chmiel JF, Aksamit TR, Chotirmall SH, Dasenbrook EC, Elborn JS, LiPuma JJ, Ranganathan SC, Waters VJ, Ratjen FA. Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections. Annals of the American Thoracic Society. 11: 1120-9. PMID 25102221 DOI: 10.1513/AnnalsATS.201402-050AS |
0.342 |
|
| 2014 |
Daines C, VanDeVanter D, Khan U, Emerson J, Heltshe S, McNamara S, Anstead M, Langkamp M, Doring G, Ratjen F, Ramsey B, Gibson RL, Morgan W, Rosenfeld M. Serology as a diagnostic tool for predicting initialPseudomonas aeruginosa acquisition in children with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 13: 542-9. PMID 25027419 DOI: 10.1016/J.Jcf.2014.06.005 |
0.462 |
|
| 2014 |
Jaecklin T, Duerr J, Huang H, Rafii M, Bear CE, Ratjen F, Pencharz P, Kavanagh BP, Mall MA, Grasemann H. Lung arginase expression and activity is increased in cystic fibrosis mouse models. Journal of Applied Physiology (Bethesda, Md. : 1985). 117: 284-8. PMID 24925982 DOI: 10.1152/Japplphysiol.00167.2014 |
0.426 |
|
| 2014 |
Waters V, Ratjen F. Inhaled liposomal amikacin. Expert Review of Respiratory Medicine. 8: 401-9. PMID 24882271 DOI: 10.1586/17476348.2014.918507 |
0.463 |
|
| 2014 |
Smyth AR, Bell SC, Bojcin S, Bryon M, Duff A, Flume P, Kashirskaya N, Munck A, Ratjen F, Schwarzenberg SJ, Sermet-Gaudelus I, Southern KW, Taccetti G, Ullrich G, Wolfe S, et al. European Cystic Fibrosis Society Standards of Care: Best Practice guidelines. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 13: S23-42. PMID 24856775 DOI: 10.1016/J.Jcf.2014.03.010 |
0.362 |
|
| 2014 |
Latino GA, Al-Saleh S, Carpenter S, Ratjen F. The diagnostic yield of rescreening for arteriovenous malformations in children with hereditary hemorrhagic telangiectasia. The Journal of Pediatrics. 165: 197-9. PMID 24797954 DOI: 10.1016/J.Jpeds.2014.03.040 |
0.317 |
|
| 2014 |
Brumback LC, Baines A, Ratjen F, Davis SD, Daniel SL, Quittner AL, Rosenfeld M. Pulmonary exacerbations and parent-reported outcomes in children <6 years with cystic fibrosis. Pediatric Pulmonology. PMID 24777957 DOI: 10.1002/Ppul.23056 |
0.59 |
|
| 2014 |
Carpenter S, Josepovici J, Latino G, Ratjen F. Positional oximetry to screen for pulmonary arteriovenous malformations in HHT. Thorax. 69: 1045. PMID 24706042 DOI: 10.1136/Thoraxjnl-2013-205028 |
0.399 |
|
| 2014 |
Mehl A, Ghorbani P, Douda D, Huang H, Palaniyar N, Ratjen F, Grasemann H. Effect of arginase inhibition on pulmonary L-arginine metabolism in murine Pseudomonas pneumonia. Plos One. 9: e90232. PMID 24595185 DOI: 10.1371/Journal.Pone.0090232 |
0.315 |
|
| 2014 |
Amin R, Ratjen F. Emerging drugs for cystic fibrosis. Expert Opinion On Emerging Drugs. 19: 143-55. PMID 24479826 DOI: 10.1517/14728214.2014.882316 |
0.437 |
|
| 2014 |
Sweezey NB, Ratjen F. The cystic fibrosis gender gap: potential roles of estrogen. Pediatric Pulmonology. 49: 309-17. PMID 24339235 DOI: 10.1002/Ppul.22967 |
0.485 |
|
| 2014 |
Schneiderman JE, Wilkes DL, Atenafu EG, Nguyen T, Wells GD, Alarie N, Tullis E, Lands LC, Coates AL, Corey M, Ratjen F. Longitudinal relationship between physical activity and lung health in patients with cystic fibrosis. The European Respiratory Journal. 43: 817-23. PMID 24176992 DOI: 10.1183/09031936.00055513 |
0.429 |
|
| 2014 |
Wells GD, Wilkes DL, Schneiderman JE, Thompson S, Coates AL, Ratjen F. Physiological correlates of pulmonary function in children with cystic fibrosis. Pediatric Pulmonology. 49: 878-84. PMID 24166871 DOI: 10.1002/Ppul.22928 |
0.429 |
|
| 2014 |
Stanojevic S, Waters V, Mathew JL, Taylor L, Ratjen F. Effectiveness of inhaled tobramycin in eradicating Pseudomonas aeruginosa in children with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 13: 172-8. PMID 24091166 DOI: 10.1016/J.Jcf.2013.09.002 |
0.451 |
|
| 2014 |
Anstead M, Saiman L, Mayer-Hamblett N, Lands LC, Kloster M, Goss CH, Rose L, Burns JL, Marshall B, Ratjen F. Pulmonary exacerbations in CF patients with early lung disease. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 13: 74-9. PMID 24029220 DOI: 10.1016/J.Jcf.2013.07.006 |
0.493 |
|
| 2014 |
Boyce MA, Stanojevic S, Kowalik K, Balkovec S, Ratjen F, Sears MR, Subbarao P. Are known biomarkers for asthma present in early infancy? Allergy, Asthma & Clinical Immunology. 10. DOI: 10.1186/1710-1492-10-S1-A48 |
0.315 |
|
| 2014 |
McIlwaine M, Richmond M, Agnew J, Alarie N, Lands L, Chilvers M, Ratjen F. WS5.6 Cost-effectiveness of performing positive expiratory pressure versus high frequency chest wall oscillation Journal of Cystic Fibrosis. 13: S11. DOI: 10.1016/S1569-1993(14)60036-9 |
0.304 |
|
| 2014 |
Hayeems RZ, Miller FA, Barg CJ, Bombard Y, Durie P, Chakraborty P, Potter BK, Bytautas JP, Tam K, Taylor L, Kerr E, Davies C, Milburn J, Keenan K, Ratjen F, et al. In the loop: Primary care providers' role in newborn screening for cystic fibrosis Clinical Biochemistry. 47: 147-148. DOI: 10.1016/J.Clinbiochem.2014.07.069 |
0.327 |
|
| 2014 |
Tam K, Taylor L, Gonska T, Solomon M, Ratjen F. We are the 1%: Newborn screening for cystic fibrosis and true positive cases from category C screening Clinical Biochemistry. 47: 135-136. DOI: 10.1016/J.Clinbiochem.2014.07.034 |
0.301 |
|
| 2014 |
Barg CJ, Miller FA, Hayeems RZ, Bombard Y, Durie P, Carroll JC, Chakraborty P, Potter BK, Bytautas JP, Tam K, Taylor L, Kerr E, Davies C, Milburn J, Keenan K, ... Ratjen F, et al. Making sense of diagnostic uncertainty after newborn screening for cystic fibrosis Clinical Biochemistry. 47: 135. DOI: 10.1016/J.Clinbiochem.2014.07.033 |
0.349 |
|
| 2014 |
Bombard Y, Miller FA, Hayeems RZ, Barg CJ, Patton SJ, Durie P, Carroll JC, Chakraborty P, Potter BK, Tam K, Taylor L, Kerr E, Davies C, Milburn J, Keenan K, ... Ratjen F, et al. How does learning false positive results through newborn screening for cystic fibrosis influence cascade testing and family planning Clinical Biochemistry. 47: 134-135. DOI: 10.1016/J.Clinbiochem.2014.07.031 |
0.309 |
|
| 2013 |
Davies J, Sheridan H, Bell N, Cunningham S, Davis SD, Elborn JS, Milla CE, Starner TD, Weiner DJ, Lee PS, Ratjen F. Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry: a randomised controlled trial. The Lancet. Respiratory Medicine. 1: 630-8. PMID 24461666 DOI: 10.1016/S2213-2600(13)70182-6 |
0.649 |
|
| 2013 |
Grasemann H, Ratjen F. Early lung disease in cystic fibrosis. The Lancet. Respiratory Medicine. 1: 148-57. PMID 24429095 DOI: 10.1016/S2213-2600(13)70026-2 |
0.492 |
|
| 2013 |
Mayer-Hamblett N, Ratjen F. Acute antibiotic use in cystic fibrosis clinical trials: does it affect our assessment of clinical efficacy? The Lancet. Respiratory Medicine. 1: 98-9. PMID 24429079 DOI: 10.1016/S2213-2600(13)70013-4 |
0.341 |
|
| 2013 |
Grasemann H, Ratjen F, Solomon M. Aquagenic wrinkling of the palms in a patient with cystic fibrosis. The New England Journal of Medicine. 369: 2362-3. PMID 24328486 DOI: 10.1056/Nejmc1308349 |
0.427 |
|
| 2013 |
Tam J, Nash EF, Ratjen F, Tullis E, Stephenson A. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis. The Cochrane Database of Systematic Reviews. 7: CD007168. PMID 23852992 DOI: 10.1002/14651858.Cd007168.Pub3 |
0.464 |
|
| 2013 |
Mayer-Hamblett N, Saiman L, Lands LC, Anstead M, Rosenfeld M, Kloster M, Fisher L, Ratjen F. Impact of acute antibiotic therapy on the pulmonary exacerbation endpoint in cystic fibrosis clinical trials. Contemporary Clinical Trials. 36: 99-105. PMID 23770109 DOI: 10.1016/J.Cct.2013.06.004 |
0.42 |
|
| 2013 |
Stanojevic S, Ratjen F, Stephens D, Lu A, Yau Y, Tullis E, Waters V. Factors influencing the acquisition of Stenotrophomonas maltophilia infection in cystic fibrosis patients. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 12: 575-83. PMID 23757360 DOI: 10.1016/J.Jcf.2013.05.009 |
0.361 |
|
| 2013 |
Subbarao P, Stanojevic S, Brown M, Jensen R, Rosenfeld M, Davis S, Brumback L, Gustafsson P, Ratjen F. Lung clearance index as an outcome measure for clinical trials in young children with cystic fibrosis. A pilot study using inhaled hypertonic saline. American Journal of Respiratory and Critical Care Medicine. 188: 456-60. PMID 23742699 DOI: 10.1164/Rccm.201302-0219Oc |
0.652 |
|
| 2013 |
Goss CH, Ratjen F. Update in cystic fibrosis 2012. American Journal of Respiratory and Critical Care Medicine. 187: 915-9. PMID 23634859 DOI: 10.1164/Rccm.201301-0184Up |
0.471 |
|
| 2013 |
Latino GA, Al-Saleh S, Alharbi N, Edwards C, Faughnan ME, Ratjen F. Prevalence of pulmonary arteriovenous malformations in children versus adults with hereditary hemorrhagic telangiectasia. The Journal of Pediatrics. 163: 282-4. PMID 23522378 DOI: 10.1016/J.Jpeds.2013.02.021 |
0.395 |
|
| 2013 |
Stick S, Tiddens H, Aurora P, Gustafsson P, Ranganathan S, Robinson P, Rosenfeld M, Sly P, Ratjen F. Early intervention studies in infants and preschool children with cystic fibrosis: are we ready? The European Respiratory Journal. 42: 527-38. PMID 23520316 DOI: 10.1183/09031936.00108212 |
0.48 |
|
| 2013 |
Jensen R, Stanojevic S, Gibney K, Salazar JG, Gustafsson P, Subbarao P, Ratjen F. Multiple breath nitrogen washout: a feasible alternative to mass spectrometry. Plos One. 8: e56868. PMID 23457632 DOI: 10.1371/Journal.Pone.0056868 |
0.439 |
|
| 2013 |
McIlwaine MP, Alarie N, Davidson GF, Lands LC, Ratjen F, Milner R, Owen B, Agnew JL. Long-term multicentre randomised controlled study of high frequency chest wall oscillation versus positive expiratory pressure mask in cystic fibrosis. Thorax. 68: 746-51. PMID 23407019 DOI: 10.1136/Thoraxjnl-2012-202915 |
0.364 |
|
| 2013 |
Robinson PD, Latzin P, Verbanck S, Hall GL, Horsley A, Gappa M, Thamrin C, Arets HG, Aurora P, Fuchs SI, King GG, Lum S, Macleod K, Paiva M, Pillow JJ, ... ... Ratjen F, et al. Consensus statement for inert gas washout measurement using multiple- and single- breath tests. The European Respiratory Journal. 41: 507-22. PMID 23397305 DOI: 10.1183/09031936.00069712 |
0.331 |
|
| 2013 |
Grasemann H, Tullis E, Ratjen F. A randomized controlled trial of inhaled L-arginine in patients with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 12: 468-74. PMID 23333044 DOI: 10.1016/J.Jcf.2012.12.008 |
0.429 |
|
| 2013 |
Waters V, Atenafu EG, Lu A, Yau Y, Tullis E, Ratjen F. Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 12: 482-6. PMID 23294530 DOI: 10.1016/J.Jcf.2012.12.006 |
0.469 |
|
| 2013 |
Rosenfeld M, Ratjen F, Brumback L, Daniel S, Rowbotham R, Mc Namara S, Johnson R, Kronmal R, Davis SD. Inhaled Hypertonic Saline in Infants and Children Younger Than 6 Years With Cystic Fibrosis (ISIS) Survey of Anesthesiology. 57: 30. DOI: 10.1097/Sa.0B013E31827F338C |
0.582 |
|
| 2013 |
Geller D, Koker P, Elborn JS, Maulf FL, Kattenbeck S, Moroni-Zentgraf P, Ratjen F. 64 Tiotropium in cystic fibrosis: Pooled analysis of phase II and III randomized, controlled trials Journal of Cystic Fibrosis. 12. DOI: 10.1016/S1569-1993(13)60206-4 |
0.306 |
|
| 2013 |
Accurso FJ, Ratjen F, Altes T, Lubarsky B, Dong Q, Kang L, Davies J. 56 Effect of withdrawal of ivacaftor therapy on CFTR channel activity and lung function in patients with cystic fibrosis Journal of Cystic Fibrosis. 12. DOI: 10.1016/S1569-1993(13)60198-8 |
0.429 |
|
| 2013 |
McIlwaine M, Agnew J, Alarie N, Lands L, Davidson G, Ratjen F. WS9.1 Effectiveness of airway clearance techniques when patients choose their airway clearance technique Journal of Cystic Fibrosis. 12: S18. DOI: 10.1016/S1569-1993(13)60052-1 |
0.351 |
|
| 2012 |
Griese M, Heinrich S, Ratjen F, Kabesch M, Paul K, Ballmann M, Rietschel E, Kappler M. Surfactant protein a in cystic fibrosis: supratrimeric structure and pulmonary outcome. Plos One. 7: e51050. PMID 23236429 DOI: 10.1371/Journal.Pone.0051050 |
0.438 |
|
| 2012 |
Waters V, Ratjen F. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. The Cochrane Database of Systematic Reviews. 12: CD010004. PMID 23235684 DOI: 10.1002/14651858.CD010004.pub2 |
0.366 |
|
| 2012 |
Amin R, Noone PG, Ratjen F. Chemical pleurodesis versus surgical intervention for persistent and recurrent pneumothoraces in cystic fibrosis. The Cochrane Database of Systematic Reviews. 12: CD007481. PMID 23235645 DOI: 10.1002/14651858.Cd007481.Pub3 |
0.351 |
|
| 2012 |
Waters V, Ratjen F. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis. The Cochrane Database of Systematic Reviews. 11: CD009528. PMID 23152277 DOI: 10.1002/14651858.CD009528.pub2 |
0.304 |
|
| 2012 |
Grasemann H, Shehnaz D, Enomoto M, Leadley M, Belik J, Ratjen F. L-ornithine derived polyamines in cystic fibrosis airways. Plos One. 7: e46618. PMID 23071598 DOI: 10.1371/Journal.Pone.0046618 |
0.468 |
|
| 2012 |
Wong AP, Bear CE, Chin S, Pasceri P, Thompson TO, Huan LJ, Ratjen F, Ellis J, Rossant J. Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein. Nature Biotechnology. 30: 876-82. PMID 22922672 DOI: 10.1038/Nbt.2328 |
0.397 |
|
| 2012 |
Ratjen F. Cystic fibrosis: the role of the small airways. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 25: 261-4. PMID 22857153 DOI: 10.1089/Jamp.2011.0923 |
0.498 |
|
| 2012 |
Amin R, Charron M, Grinblat L, Shammas A, Grasemann H, Graniel K, Ciet P, Tiddens H, Ratjen F. Cystic fibrosis: detecting changes in airway inflammation with FDG PET/CT. Radiology. 264: 868-75. PMID 22829680 DOI: 10.1148/Radiol.12111873 |
0.324 |
|
| 2012 |
Saiman L, Mayer-Hamblett N, Anstead M, Lands LC, Kloster M, Goss CH, Rose LM, Burns JL, Marshall BC, Ratjen F. Open-label, follow-on study of azithromycin in pediatric patients with CF uninfected with Pseudomonas aeruginosa. Pediatric Pulmonology. 47: 641-8. PMID 22684984 DOI: 10.1002/Ppul.21601 |
0.463 |
|
| 2012 |
Ratjen F, Durham T, Navratil T, Schaberg A, Accurso FJ, Wainwright C, Barnes M, Moss RB. Long term effects of denufosol tetrasodium in patients with cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 11: 539-49. PMID 22682898 DOI: 10.1016/J.Jcf.2012.05.003 |
0.426 |
|
| 2012 |
Rosenfeld M, Ratjen F, Brumback L, Daniel S, Rowbotham R, McNamara S, Johnson R, Kronmal R, Davis SD. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial. Jama. 307: 2269-77. PMID 22610452 DOI: 10.1001/Jama.2012.5214 |
0.614 |
|
| 2012 |
Naito Y, Beres A, Lapidus-Krol E, Ratjen F, Langer JC. Does earlier lobectomy result in better long-term pulmonary function in children with congenital lung anomalies? A prospective study. Journal of Pediatric Surgery. 47: 852-6. PMID 22595560 DOI: 10.1016/J.Jpedsurg.2012.01.037 |
0.445 |
|
| 2012 |
Ratjen F, Saiman L, Mayer-Hamblett N, Lands LC, Kloster M, Thompson V, Emmett P, Marshall B, Accurso F, Sagel S, Anstead M. Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa. Chest. 142: 1259-66. PMID 22595153 DOI: 10.1378/Chest.12-0628 |
0.417 |
|
| 2012 |
Aaron SD, Vandemheen KL, Freitag A, Pedder L, Cameron W, Lavoie A, Paterson N, Wilcox P, Rabin H, Tullis E, Morrison N, Ratjen F. Treatment of Aspergillus fumigatus in patients with cystic fibrosis: a randomized, placebo-controlled pilot study. Plos One. 7: e36077. PMID 22563440 DOI: 10.1371/Journal.Pone.0036077 |
0.477 |
|
| 2012 |
Ratjen F, McColley SA. Update in cystic fibrosis 2011. American Journal of Respiratory and Critical Care Medicine. 185: 933-6. PMID 22550209 DOI: 10.1164/Rccm.201202-0306Up |
0.471 |
|
| 2012 |
Warren TA, Yau Y, Ratjen F, Tullis E, Waters V. Serum galactomannan in cystic fibrosis patients colonized with Aspergillus species. Medical Mycology. 50: 658-60. PMID 22524639 DOI: 10.3109/13693786.2012.676739 |
0.382 |
|
| 2012 |
Grasemann H, Ratjen F. Nitric oxide and L-arginine deficiency in cystic fibrosis. Current Pharmaceutical Design. 18: 726-36. PMID 22229575 DOI: 10.2174/138161212799315911 |
0.369 |
|
| 2012 |
Ratjen F, Grasemann H. New therapies in cystic fibrosis. Current Pharmaceutical Design. 18: 614-27. PMID 22229570 DOI: 10.2174/138161212799315984 |
0.463 |
|
| 2012 |
Al-Saleh S, Dragulescu A, Manson D, Golding F, Traubici J, Mei-Zahav M, Maclusky IB, Faughnan ME, Carpenter S, Ratjen F. Utility of contrast echocardiography for pulmonary arteriovenous malformation screening in pediatric hereditary hemorrhagic telangiectasia. The Journal of Pediatrics. 160: 1039-43.e1. PMID 22196589 DOI: 10.1016/J.Jpeds.2011.11.038 |
0.34 |
|
| 2012 |
Waters V, Stanojevic S, Atenafu EG, Lu A, Yau Y, Tullis E, Ratjen F. Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis. The European Respiratory Journal. 40: 61-6. PMID 22135280 DOI: 10.1183/09031936.00159111 |
0.497 |
|
| 2012 |
Konstan MW, Ratjen F. Effect of dornase alfa on inflammation and lung function: potential role in the early treatment of cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 11: 78-83. PMID 22093951 DOI: 10.1016/J.Jcf.2011.10.003 |
0.521 |
|
| 2012 |
Corvol H, Beucher J, Boëlle PY, Busson PF, Muselet-Charlier C, Clement A, Ratjen F, Grasemann H, Laki J, Palmer CN, Elborn JS, Mehta A. Ancestral haplotype 8.1 and lung disease severity in European cystic fibrosis patients. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 11: 63-7. PMID 21993476 DOI: 10.1016/J.Jcf.2011.09.006 |
0.468 |
|
| 2012 |
Waters V, Atenafu EG, Salazar JG, Lu A, Yau Y, Matukas L, Tullis E, Ratjen F. Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 11: 8-13. PMID 21849265 DOI: 10.1016/J.Jcf.2011.07.008 |
0.442 |
|
| 2012 |
Ratjen F, Rosenfeld M, Brumback L, Daniel S, Rowbotham R, Kronmal R, Davis S. WS22.1 Efficacy of hypertonic saline in infants and young children: the ISIS study Journal of Cystic Fibrosis. 11: S50. DOI: 10.1016/S1569-1993(12)60157-X |
0.519 |
|
| 2012 |
Davies JC, Sheridan H, Lee P-, Song T, Stone A, Ratjen F. WS7.6 Effect of ivacaftor on lung function in subjects with CF who have the G551D-CFTR mutation and mild lung disease: a comparison of lung clearance index (LCI) vs. spirometry Journal of Cystic Fibrosis. 11. DOI: 10.1016/S1569-1993(12)60049-6 |
0.446 |
|
| 2011 |
Ramsey BW, Davies J, McElvaney NG, Tullis E, Bell SC, DÅ™evÃnek P, Griese M, McKone EF, Wainwright CE, Konstan MW, Moss R, Ratjen F, Sermet-Gaudelus I, Rowe SM, Dong Q, et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. The New England Journal of Medicine. 365: 1663-72. PMID 22047557 DOI: 10.1056/Nejmoa1105185 |
0.436 |
|
| 2011 |
Osborn AJ, Leung R, Ratjen F, James AL. Effect of endoscopic sinus surgery on pulmonary function and microbial pathogens in a pediatric population with cystic fibrosis. Archives of Otolaryngology--Head & Neck Surgery. 137: 542-7. PMID 21690506 DOI: 10.1001/Archoto.2011.68 |
0.383 |
|
| 2011 |
Green N, Burns JL, Mayer-Hamblett N, Kloster M, Lands LC, Anstead M, Ratjen F, Saiman L. Lack of association of small-colony-variant Staphylococcus aureus strains with long-term use of azithromycin in patients with cystic fibrosis. Journal of Clinical Microbiology. 49: 2772-3. PMID 21543567 DOI: 10.1128/Jcm.00835-11 |
0.354 |
|
| 2011 |
Mateos-Corral D, Coombs R, Grasemann H, Ratjen F, Dell SD. Diagnostic value of nasal nitric oxide measured with non-velum closure techniques for children with primary ciliary dyskinesia. The Journal of Pediatrics. 159: 420-4. PMID 21514598 DOI: 10.1016/J.Jpeds.2011.03.007 |
0.322 |
|
| 2011 |
Eber E, Lødrup Carlsen KC, Ratjen F, Turner SW, Dankert-Roelse JE, Ross-Russell RI, Midulla F, Aurora P, Hedlin G. Paediatrics in Barcelona: highlights from the 2010 ERS Annual Congress. The European Respiratory Journal. 37: 1514-21. PMID 21478214 DOI: 10.1183/09031936.00026311 |
0.346 |
|
| 2011 |
Rosenfeld M, Davis S, Brumback L, Daniel S, Rowbotham R, Johnson R, McNamara S, Jensen R, Barlow C, Ratjen F. Inhaled hypertonic saline in infants and toddlers with cystic fibrosis: short-term tolerability, adherence, and safety. Pediatric Pulmonology. 46: 666-71. PMID 21365779 DOI: 10.1002/Ppul.21425 |
0.577 |
|
| 2011 |
Coates AL, Green M, Leung K, Chan J, Ribeiro N, Ratjen F, Charron M. A comparison of amount and speed of deposition between the PARI LC STAR® jet nebulizer and an investigational eFlow® nebulizer. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 24: 157-63. PMID 21361784 DOI: 10.1089/Jamp.2010.0861 |
0.34 |
|
| 2011 |
Amin R, Lam M, Dupuis A, Ratjen F. The effect of early Pseudomonas aeruginosa treatment on lung function in pediatric cystic fibrosis. Pediatric Pulmonology. 46: 554-8. PMID 21337727 DOI: 10.1002/Ppul.21417 |
0.485 |
|
| 2011 |
Leahy TR, Yau YC, Atenafu E, Corey M, Ratjen F, Waters V. Epidemiology of borderline oxacillin-resistant Staphylococcus aureus in pediatric cystic fibrosis. Pediatric Pulmonology. 46: 489-96. PMID 21337531 DOI: 10.1002/Ppul.21383 |
0.393 |
|
| 2011 |
Grasemann H, Al-Saleh S, Scott JA, Shehnaz D, Mehl A, Amin R, Rafii M, Pencharz P, Belik J, Ratjen F. Asymmetric dimethylarginine contributes to airway nitric oxide deficiency in patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 183: 1363-8. PMID 21278301 DOI: 10.1164/Rccm.201012-1995Oc |
0.356 |
|
| 2011 |
Wells GD, Wilkes DL, Schneiderman JE, Rayner T, Elmi M, Selvadurai H, Dell SD, Noseworthy MD, Ratjen F, Tein I, Coates AL. Skeletal muscle metabolism in cystic fibrosis and primary ciliary dyskinesia. Pediatric Research. 69: 40-5. PMID 20938370 DOI: 10.1203/Pdr.0B013E3181Fff35F |
0.362 |
|
| 2011 |
Waters V, Yau Y, Prasad S, Lu A, Atenafu E, Crandall I, Tom S, Tullis E, Ratjen F. Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. American Journal of Respiratory and Critical Care Medicine. 183: 635-40. PMID 20889901 DOI: 10.1164/Rccm.201009-1392Oc |
0.499 |
|
| 2011 |
Amin R, Subbarao P, Lou W, Jabar A, Balkovec S, Jensen R, Kerrigan S, Gustafsson P, Ratjen F. The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis. The European Respiratory Journal. 37: 806-12. PMID 20693248 DOI: 10.1183/09031936.00072510 |
0.412 |
|
| 2011 |
Grasemann H, Tullis E, Ratjen F. 81* Inhaled L-arginine in patients with cystic fibrosis – a randomized controlled trial Journal of Cystic Fibrosis. 10. DOI: 10.1016/S1569-1993(11)60099-4 |
0.359 |
|
| 2010 |
Barnes PJ, Dweik RA, Gelb AF, Gibson PG, George SC, Grasemann H, Pavord ID, Ratjen F, Silkoff PE, Taylor DR, Zamel N. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest. 138: 682-92. PMID 20822990 DOI: 10.1378/Chest.09-2090 |
0.367 |
|
| 2010 |
Grasemann H, Ratjen F. Emerging therapies for cystic fibrosis lung disease. Expert Opinion On Emerging Drugs. 15: 653-9. PMID 20812885 DOI: 10.1517/14728214.2010.517746 |
0.434 |
|
| 2010 |
Hedlin G, Eber E, Aurora P, Lødrup Carlsen KC, Ratjen F, Dankert-Roelse JE, Ross-Russell RI, Turner S, Midulla F, Baraldi E, Bush A. Paediatric respiratory disease: past, present and future. The European Respiratory Journal. 36: 225-8. PMID 20675775 DOI: 10.1183/09031936.00085510 |
0.461 |
|
| 2010 |
Al-Saleh S, Dell SD, Grasemann H, Yau YC, Waters V, Martin S, Ratjen F. Sputum induction in routine clinical care of children with cystic fibrosis. The Journal of Pediatrics. 157: 1006-1011.e1. PMID 20630539 DOI: 10.1016/J.Jpeds.2010.06.001 |
0.446 |
|
| 2010 |
Amin R, Ratjen F. MRI: the next frontier for cystic fibrosis clinicians? Expert Review of Respiratory Medicine. 2: 179-82. PMID 20477247 DOI: 10.1586/17476348.2.2.179 |
0.303 |
|
| 2010 |
Amin R, Ratjen F. MRI: the next frontier for cystic fibrosis clinicians? Expert Review of Respiratory Medicine. 2: 179-82. PMID 20477247 DOI: 10.1586/17476348.2.2.179 |
0.303 |
|
| 2010 |
Saiman L, Anstead M, Mayer-Hamblett N, Lands LC, Kloster M, Hocevar-Trnka J, Goss CH, Rose LM, Burns JL, Marshall BC, Ratjen F. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial. Jama. 303: 1707-15. PMID 20442386 DOI: 10.1001/Jama.2010.563 |
0.484 |
|
| 2010 |
Amin R, Subbarao P, Jabar A, Balkovec S, Jensen R, Kerrigan S, Gustafsson P, Ratjen F. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. Thorax. 65: 379-83. PMID 20435858 DOI: 10.1136/Thx.2009.125831 |
0.492 |
|
| 2010 |
Ulrich M, Worlitzsch D, Viglio S, Siegmann N, Iadarola P, Shute JK, Geiser M, Pier GB, Friedel G, Barr ML, Schuster A, Meyer KC, Ratjen F, Bjarnsholt T, Gulbins E, et al. Alveolar inflammation in cystic fibrosis. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society. 9: 217-27. PMID 20347403 DOI: 10.1016/J.Jcf.2010.03.001 |
0.497 |
|
| 2010 |
Brand PLP, Ratjen F, Aurora P, Dankert-Roelse JE, Ross-Russell RI, Kuehni CE, Midulla F, Hedlin G. Paediatrics in Vienna European Respiratory Journal. 35: 1172-1178. PMID 20075043 DOI: 10.1183/09031936.00198009 |
0.346 |
|
| 2010 |
Ratjen F, Munck A, Kho P, Angyalosi G. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial. Thorax. 65: 286-91. PMID 19996339 DOI: 10.1136/Thx.2009.121657 |
0.403 |
|
| 2010 |
Smyth AR, Barbato A, Beydon N, Bisgaard H, De Boeck K, Brand P, Bush A, Fauroux B, De Jongste J, Korppi M, O'Callaghan C, Pijnenburg M, Ratjen F, Southern K, Spencer D, et al. Respiratory medicines for children: Current evidence, unlicensed use and research priorities European Respiratory Journal. 35: 247-265. PMID 19840958 DOI: 10.1183/09031936.00139508 |
0.388 |
|
| 2010 |
Amin R, Dupuis A, Aaron SD, Ratjen F. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis Chest. 137: 171-176. PMID 19567494 DOI: 10.1378/Chest.09-1103 |
0.527 |
|
| 2010 |
Navratil T, Evans C, Schaberg A, Johnson F, Durham T, Ren C, Ratjen F, Moss R, Accurso F. Aerosol and pharmacokinetic properties of denufosol support its use for early intervention in CF lung disease Journal of Cystic Fibrosis. 9: S21. DOI: 10.1016/S1569-1993(10)60079-3 |
0.41 |
|
| 2010 |
Corvol H, Beucher J, Boelle P, Clement A, Ratjen F, Grasemann H, Laki J, Palmer C, Elborn S, Mehta A. A European meta-analysis of ancestral haplotype 8.1 and lung disease severity in cystic fibrosis Pediatric Pulmonology. 45: 282-283. DOI: 10.1002/Ppul.21339 |
0.453 |
|
| 2010 |
Ratjen F. Airway inflammation in cystic fibrosis Canadian Respiratory Journal. 17: e40-e41. |
0.343 |
|
| 2009 |
Bendiak GN, Ratjen F. The approach to pseudomonas aeruginosa in cystic fibrosis Seminars in Respiratory and Critical Care Medicine. 30: 587-595. PMID 19760546 DOI: 10.1055/S-0029-1238917 |
0.397 |
|
| 2009 |
Ratjen F, Brockhaus F, Angyalosi G. Aminoglycoside therapy against Pseudomonas aeruginosa in cystic fibrosis: A review Journal of Cystic Fibrosis. 8: 361-369. PMID 19747887 DOI: 10.1016/J.Jcf.2009.08.004 |
0.422 |
|
| 2009 |
Mateos-Corral D, Cutz E, Solomon M, Ratjen F. Plastic bronchitis as an unusual cause of mucus plugging in cystic fibrosis Pediatric Pulmonology. 44: 939-940. PMID 19658112 DOI: 10.1002/Ppul.21063 |
0.437 |
|
| 2009 |
Wilkes DL, Schneiderman JE, Nguyen T, Heale L, Moola F, Ratjen F, Coates AL, Wells GD. Exercise and physical activity in children with cystic fibrosis. Paediatric Respiratory Reviews. 10: 105-9. PMID 19651380 DOI: 10.1016/J.Prrv.2009.04.001 |
0.345 |
|
| 2009 |
Keijzer R, Chiu PP, Ratjen F, Langer JC. Pulmonary function after early vs late lobectomy during childhood: a preliminary study. Journal of Pediatric Surgery. 44: 893-5. PMID 19433164 DOI: 10.1016/J.Jpedsurg.2009.01.021 |
0.394 |
|
| 2009 |
Ratjen FA. Cystic fibrosis: Pthogenesis and future treatment strategies Respiratory Care. 54: 595-602. PMID 19393104 DOI: 10.4187/aarc0427 |
0.353 |
|
| 2009 |
Al-Saleh S, Mei-Zahav M, Faughnan ME, MacLusky IB, Carpenter S, Letarte M, Ratjen F. Screening for pulmonary and cerebral arteriovenous malformations in children with hereditary haemorrhagic telangiectasia. The European Respiratory Journal. 34: 875-81. PMID 19386691 DOI: 10.1183/09031936.00030009 |
0.41 |
|
| 2009 |
Ratjen F. Update in cystic fibrosis 2008 American Journal of Respiratory and Critical Care Medicine. 179: 445-448. PMID 19264980 DOI: 10.1164/Rccm.200812-1927Up |
0.482 |
|
| 2009 |
Nash EF, Stephenson A, Ratjen F, Tullis E. Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis. The Cochrane Database of Systematic Reviews. CD007168. PMID 19160327 DOI: 10.1002/14651858.CD007168.pub2 |
0.359 |
|
| 2008 |
Barbato A, Bertuola F, Kuehni C, Korppi M, Kotecha S, Pijnenburg MW, Ratjen F, Seddon P, Bush A. Paediatrics in Berlin European Respiratory Journal. 34: 436-443. PMID 19648520 DOI: 10.1183/09031936.00038809 |
0.346 |
|
| 2008 |
Ratjen F, Bush A. Amiloride: Still a viable treatment option in cystic fibrosis? American Journal of Respiratory and Critical Care Medicine. 178: 1191-1192. PMID 19050201 DOI: 10.1164/Rccm.200805-795Ed |
0.384 |
|
| 2008 |
Amin R, Ratjen F. Cystic Fibrosis: a Review of Pulmonary and Nutritional Therapies Advances in Pediatrics. 55: 99-121. PMID 19048729 DOI: 10.1016/J.Yapd.2008.07.015 |
0.43 |
|
| 2008 |
Corvol H, Boelle PY, Brouard J, Knauer N, Chadelat K, Henrion-Caude A, Flamant C, Muselet-Charlier C, Boule M, Fauroux B, Vallet C, Feingold J, Ratjen F, Grasemann H, Clement A. Genetic variations in inflammatory mediators influence lung disease progression in cystic fibrosis. Pediatric Pulmonology. 43: 1224-32. PMID 19009622 DOI: 10.1002/Ppul.20935 |
0.427 |
|
| 2008 |
Wells GD, Heale L, Schneiderman JE, Wilkes DL, Atenafu E, Coates AL, Ratjen F. Assessment of body composition in pediatric patients with cystic fibrosis. Pediatric Pulmonology. 43: 1025-32. PMID 18781652 DOI: 10.1002/Ppul.20913 |
0.463 |
|
| 2008 |
Nikolaizik WH, Vietzke D, Ratjen F. A pilot study to compare tobramycin 80 mg injectable preparation with 300 mg solution for inhalation in cystic fibrosis patients Canadian Respiratory Journal. 15: 259-262. PMID 18716688 DOI: 10.1155/2008/202464 |
0.459 |
|
| 2008 |
Coates AL, Green M, Leung K, Chan J, Ribeiro N, Louca E, Ratjen F, Charron M, Tservistas M, Keller M. Rapid pulmonary delivery of inhaled tobramycin for Pseudomonas infection in cystic fibrosis: a pilot project. Pediatric Pulmonology. 43: 753-9. PMID 18613006 DOI: 10.1002/Ppul.20850 |
0.448 |
|
| 2008 |
Davis SD, Ratjen F. Reduced lung function in cystic fibrosis: a primary or secondary phenotype? American Journal of Respiratory and Critical Care Medicine. 178: 2-3. PMID 18565959 DOI: 10.1164/Rccm.200804-502Ed |
0.62 |
|
| 2008 |
Ratjen F. Recent advances in cystic fibrosis Paediatric Respiratory Reviews. 9: 144-148. PMID 18513677 DOI: 10.1016/J.Prrv.2008.01.004 |
0.426 |
|
| 2008 |
Wells GD, Wilkes DL, Schneiderman-Walker J, Elmi M, Tullis E, Lands LC, Ratjen F, Coates AL. Reliability and validity of the habitual activity estimation scale (HAES) in patients with cystic fibrosis. Pediatric Pulmonology. 43: 345-53. PMID 18306334 DOI: 10.1002/Ppul.20737 |
0.351 |
|
| 2008 |
Grasemann C, Ratjen F, Schnabel D, Reutershahn E, Vester U, Grasemann H. Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients European Respiratory Journal. 31: 815-821. PMID 18094013 DOI: 10.1183/09031936.00103907 |
0.313 |
|
| 2008 |
Corvol H, Boelle PY, Brouard J, Knauer N, Henrion-Caude A, Chadelat K, Flamant C, Charlier C, Boule M, Fauroux B, Vallet C, Feingold J, Ratjen F, Grasemann H, Clement A. Cytokine polymorphisms influence lung disease progression in cystic fibrosis Journal of Cystic Fibrosis. 7. DOI: 10.1016/S1569-1993(08)60012-0 |
0.444 |
|
| 2008 |
Ratjen F. Aerosol therapy in cystic fibrosis: Weighing the evidence Pediatric Pulmonology. 43: S3-S4. DOI: 10.1002/Ppul.20861 |
0.434 |
|
| 2008 |
Nash E, Stephenson A, Ratjen F, Tullis E. Thiol derivatives for pulmonary disease in cystic fibrosis Cochrane Database of Systematic Reviews. DOI: 10.1002/14651858.Cd007168 |
0.45 |
|
| 2007 |
Ratjen F. New pulmonary therapies for cystic fibrosis Current Opinion in Pulmonary Medicine. 13: 541-546. PMID 17901762 DOI: 10.1097/Mcp.0B013E3282Efbc56 |
0.415 |
|
| 2007 |
Grasemann H, Tschiedel E, Groch M, Klepper J, Ratjen F. Exhaled nitric oxide in children after accidental exposure to chlorine gas Inhalation Toxicology. 19: 895-898. PMID 17687720 DOI: 10.1080/08958370701432157 |
0.338 |
|
| 2007 |
Ridder-Schaphorn S, Ratjen F, Dübbers A, Häberle J, Falk S, Küster P, Schuster A, Mellies U, Löwe B, Reintjes R, Peters G, Kahl BC. Nasal Staphylococcus aureus carriage is not a risk factor for lower-airway infection in young cystic fibrosis patients Journal of Clinical Microbiology. 45: 2979-2984. PMID 17652474 DOI: 10.1128/Jcm.00855-07 |
0.393 |
|
| 2007 |
Schnabel D, Grasemann C, Staab D, Wollmann H, Ratjen F. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis Pediatrics. 119: e1230-e1238. PMID 17545356 DOI: 10.1542/Peds.2006-2783 |
0.403 |
|
| 2007 |
Grasemann H, Stehling F, Brunar H, Widmann R, Laliberte TW, Molina L, Döring G, Ratjen F. Inhalation of Moli1901 in patients with cystic fibrosis Chest. 131: 1461-1466. PMID 17494794 DOI: 10.1378/Chest.06-2085 |
0.434 |
|
| 2007 |
Lam W, Tjon J, Seto W, Dekker A, Wong C, Atenafu E, Bitnun A, Waters V, Yau Y, Solomon M, Ratjen F. Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patients. The Journal of Antimicrobial Chemotherapy. 59: 1135-40. PMID 17446242 DOI: 10.1093/Jac/Dkm097 |
0.37 |
|
| 2007 |
Subbarao P, Balkovec S, Solomon M, Ratjen F. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis. Pediatric Pulmonology. 42: 471-6. PMID 17436328 DOI: 10.1002/Ppul.20603 |
0.466 |
|
| 2007 |
Henke MO, Ratjen F. Mucolytics in cystic fibrosis Paediatric Respiratory Reviews. 8: 24-29. PMID 17419975 DOI: 10.1016/J.Prrv.2007.02.009 |
0.505 |
|
| 2007 |
Ratjen F. Inhaled hypertonic saline produces small increases in lung function in patients with cystic fibrosis. The Journal of Pediatrics. 149: 142. PMID 17243308 DOI: 10.1016/J.Jpeds.2006.04.030 |
0.452 |
|
| 2007 |
Ratjen F, Walter H, Haug M, Meisner C, Grasemann H, Döring G. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients. Pediatric Pulmonology. 42: 249-55. PMID 17243185 DOI: 10.1002/Ppul.20562 |
0.324 |
|
| 2007 |
Chan EY, Avcin T, Dell S, Manson D, Cutz E, Schneider R, Ratjen F. Massive hemoptysis in an 11-year-old girl with isolated pulmonary arteritis. Pediatric Pulmonology. 42: 177-80. PMID 17186544 DOI: 10.1002/Ppul.20527 |
0.354 |
|
| 2007 |
Ratjen F. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis. Current Opinion in Pulmonary Medicine. 12: 428-32. PMID 17053493 DOI: 10.1097/01.Mcp.0000245712.51514.A1 |
0.407 |
|
| 2006 |
Waters V, Ratjen F. Multidrug-resistant organisms in cystic fibrosis: Management and infection-control issues Expert Review of Anti-Infective Therapy. 4: 807-819. PMID 17140357 DOI: 10.1586/14787210.4.5.807 |
0.357 |
|
| 2006 |
Subbarao P, Ratjen F. Beta2-agonists for asthma: the pediatric perspective. Clinical Reviews in Allergy & Immunology. 31: 209-18. PMID 17085794 DOI: 10.1385/Criai:31:2:209 |
0.306 |
|
| 2006 |
Taylor L, Corey M, Mallow A, Sweezey NB, Ratjen F. Comparison of throat swabs and nasopharyngeal suction specimens in non-sputum-producing patients with cystic fibrosis Pediatric Pulmonology. 41: 839-843. PMID 16850448 DOI: 10.1002/Ppul.20451 |
0.492 |
|
| 2006 |
Starosta V, Ratjen F, Rietschel E, Paul K, Griese M. Anti-inflammatory cytokines in cystic fibrosis lung disease. The European Respiratory Journal. 28: 581-7. PMID 16807263 DOI: 10.1183/09031936.06.00071405 |
0.437 |
|
| 2006 |
Ratjen F. What's new in CF airway inflammation: An update Paediatric Respiratory Reviews. 7: S70-S72. PMID 16798601 DOI: 10.1016/J.Prrv.2006.04.170 |
0.477 |
|
| 2006 |
Ratjen F. Diagnosing and managing infection in CF Paediatric Respiratory Reviews. 7: S151-S153. PMID 16798546 DOI: 10.1016/J.Prrv.2006.04.217 |
0.382 |
|
| 2006 |
Grasemann H, Kurtz F, Ratjen F. Inhaled L-arginine improves exhaled nitric oxide and pulmonary function in patients with cystic fibrosis American Journal of Respiratory and Critical Care Medicine. 174: 208-212. PMID 16627863 DOI: 10.1164/Rccm.200509-1439Oc |
0.408 |
|
| 2006 |
Büscher R, Hoerning A, Patel HH, Zhang S, Arthur DB, Grasemann H, Ratjen F, Insel PA. P2Y2 receptor polymorphisms and haplotypes in cystic fibrosis and their impact on Ca2+ influx. Pharmacogenetics and Genomics. 16: 199-205. PMID 16495779 DOI: 10.1097/01.Fpc.0000189798.11468.6A |
0.338 |
|
| 2006 |
Ratjen F. Restoring airway surface liquid in cystic fibrosis New England Journal of Medicine. 354: 291-293. PMID 16421371 DOI: 10.1056/Nejme058293 |
0.416 |
|
| 2006 |
Tschiedel E, Grasemann H, Ratjen F. Mycobacterium chelonae in a CF patient with anaplastic large cell lymphoma Journal of Cystic Fibrosis. 5: 133-136. PMID 16403492 DOI: 10.1016/J.Jcf.2005.11.004 |
0.383 |
|
| 2006 |
Ratjen F, Rietschel E, Kasel D, Schwiertz R, Starke K, Beier H, van Koningsbruggen S, Grasemann H. Pharmacokinetics of inhaled colistin in patients with cystic fibrosis. The Journal of Antimicrobial Chemotherapy. 57: 306-11. PMID 16396919 DOI: 10.1093/Jac/Dki461 |
0.47 |
|
| 2006 |
Ratjen F, Beier H, Grasemann H. Pharmacokinetics of inhaled colistin in patients with cystic fibrosis: Authors' response [4] Journal of Antimicrobial Chemotherapy. 58: 223. DOI: 10.1093/Jac/Dkl195 |
0.3 |
|
| 2006 |
Ratjen F, Stehling F, Starke K, Brunar H, Laliberte T, Widmann R, Molina L, Grasemann H. 45 Safety, tolerability and efficacy of multiple, rising doses of aerosolized Moli1901 in CF patients Journal of Cystic Fibrosis. 5. DOI: 10.1016/S1569-1993(06)80041-X |
0.318 |
|
| 2006 |
Brouard J, Corvol H, Boelle PY, Knauer N, Vallet C, Henrion-Caude A, Boule M, Fauroux B, Ratjen F, Grasemann H, Clément A. 19 Influence of tumor necrosis factor gene polymorphisms on lung disease progression in children with Cystic Fibrosis Journal of Cystic Fibrosis. 5. DOI: 10.1016/S1569-1993(06)80020-2 |
0.418 |
|
| 2006 |
Döring G, Ratjen F. Mucoviscidosis (Cystic Fibrosis), Molecular Cell Biology of Reviews in Cell Biology and Molecular Medicine. DOI: 10.1002/3527600906.Mcb.200400122 |
0.473 |
|
| 2005 |
Griese M, Essl R, Schmidt R, Ballmann M, Paul K, Rietschel E, Ratjen F. Sequential analysis of surfactant, lung function and inflammation in cystic fibrosis patients. Respiratory Research. 6: 133. PMID 16274485 DOI: 10.1186/1465-9921-6-133 |
0.5 |
|
| 2005 |
Grasemann H, Schwiertz R, Matthiesen S, Racké K, Ratjen F. Increased arginase activity in cystic fibrosis airways American Journal of Respiratory and Critical Care Medicine. 172: 1523-1528. PMID 16166623 DOI: 10.1164/Rccm.200502-253Oc |
0.395 |
|
| 2005 |
Hartl D, Starosta V, Maier K, Beck-Speier I, Rebhan C, Becker BF, Latzin P, Fischer R, Ratjen F, Huber RM, Rietschel E, Krauss-Etschmann S, Griese M. Inhaled glutathione decreases PGE2 and increases lymphocytes in cystic fibrosis lungs Free Radical Biology and Medicine. 39: 463-472. PMID 16043018 DOI: 10.1016/J.Freeradbiomed.2005.03.032 |
0.437 |
|
| 2005 |
Knauer N, Ratjen F, Grasemann H. Cystic fibrosis modifying genes | Modifizierende gene bei der zystischen fibrose Pneumologie. 59: 395-404. PMID 15991075 DOI: 10.1055/S-2004-830251 |
0.392 |
|
| 2005 |
Ratjen F, Rjabko O, Kremens B. High-dose corticosteroid therapy for bronchiolitis obliterans after bone marrow transplantation in children Bone Marrow Transplantation. 36: 135-138. PMID 15908967 DOI: 10.1038/Sj.Bmt.1705026 |
0.356 |
|
| 2005 |
Brouard J, Knauer N, Boelle PY, Corvol H, Henrion-Caude A, Flamant C, Bremont F, Delaisi B, Duhamel JF, Marguet C, Roussey M, Miesch MC, Chadelat K, Boule M, Fauroux B, ... Ratjen F, et al. Influence of interleukin-10 on Aspergillus fumigatus infection in patients with cystic fibrosis Journal of Infectious Diseases. 191: 1988-1991. PMID 15871134 DOI: 10.1086/429964 |
0.331 |
|
| 2005 |
Steinkamp G, Wiedemann B, Rietschel E, Krahl A, Gielen J, Bärmeier H, Ratjen F, Staab D, Brömme S, Lindemann H, Heuer H, Posselt HG, Dockter G, Schuster A, Nüßlein T, et al. Prospective evaluation of emerging bacteria in cystic fibrosis Journal of Cystic Fibrosis. 4: 41-48. PMID 15752680 DOI: 10.1016/J.Jcf.2004.10.002 |
0.432 |
|
| 2005 |
Grasemann H, Grasemann C, Kurtz F, Tietze-Schillings G, Vester U, Ratjen F. Oral L-arginine supplementation in cystic fibrosis patients: A placebo-controlled study European Respiratory Journal. 25: 62-68. PMID 15640324 DOI: 10.1183/09031936.04.00086104 |
0.337 |
|
| 2005 |
Ratjen F, Paul K, van Koningsbruggen S, Breitenstein S, Rietschel E, Nikolaizik W. DNA concentrations in BAL fluid of cystic fibrosis patients with early lung disease: influence of treatment with dornase alpha. Pediatric Pulmonology. 39: 1-4. PMID 15532079 DOI: 10.1002/Ppul.20134 |
0.411 |
|
| 2004 |
Midulla F, Guidi R, Tancredi G, Quattrucci S, Ratjen F, Bottero S, Vestiti K, Francalanci P, Cutrera R. Microaspiration in Infants with Laryngomalacia Laryngoscope. 114: 1592-1596. PMID 15475788 DOI: 10.1097/00005537-200409000-00017 |
0.328 |
|
| 2004 |
Clement A, Allen J, Corrin B, Dinwiddie R, le Pointe HD, Eber E, Laurent G, Marshall R, Midulla F, Nicholson AG, Pohunek P, Ratjen F, Spiteri M, de Blic J. Task force on chronic interstitial lung disease in immunocompetent children European Respiratory Journal. 24: 686-697. PMID 15459150 DOI: 10.1183/09031936.04.00089803 |
0.323 |
|
| 2004 |
Griese M, Essl R, Schmidt R, Rietschel E, Ratjen F, Ballmann M, Paul K. Pulmonary surfactant, lung function, and endobronchial inflammation in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 170: 1000-5. PMID 15271694 DOI: 10.1164/Rccm.200405-575Oc |
0.486 |
|
| 2004 |
Grasemann H, Ratjen F, Sharan K, Surrey S, Ballas SK, Borowski MK, Devoto M, Wang KF, Sandler E, Keller MA. Gender-specific disease modification by NOS3 (multiple letters) British Journal of Haematology. 126: 160-161. PMID 15198747 DOI: 10.1111/J.1365-2141.2004.05001.X |
0.332 |
|
| 2004 |
Ratjen F. Dornase in non-CF. Pediatric Pulmonology. Supplement. 26: 154-5. PMID 15029636 DOI: 10.1002/Ppul.70090 |
0.402 |
|
| 2004 |
Ratjen F. Early interventions in CF. Pediatric Pulmonology. Supplement. 26: 88-90. PMID 15029609 DOI: 10.1002/Ppul.70063 |
0.313 |
|
| 2004 |
Ratjen F. The infant with cystic fibrosis: inflammatory markers. Paediatric Respiratory Reviews. S365-6. PMID 14980297 DOI: 10.1016/S1526-0542(04)90064-4 |
0.337 |
|
| 2004 |
Borchers T, Dirsch O, Schaper J, Kreuzfelder E, Jakob H, Ratjen F. Nodular pulmonary vasculitis in a twelve‐year‐old boy Pediatric Pulmonology. 37: 181-185. PMID 14730665 DOI: 10.1002/Ppul.10412 |
0.332 |
|
| 2004 |
Griese M, Ramakers J, Krasselt A, Starosta V, Koningsbruggen Sv, Fischer R, Ratjen F, Müllinger B, Huber RM, Maier K, Rietschel E, Scheuch G. Improvement of Alveolar Glutathione and Lung Function but Not Oxidative State in Cystic Fibrosis American Journal of Respiratory and Critical Care Medicine. 169: 822-828. PMID 14726422 DOI: 10.1164/Rccm.200308-1104Oc |
0.452 |
|
| 2004 |
Paul K, Rietschel E, Ballmann M, Griese M, Worlitzsch D, Shute J, Chen C, Schink T, Döring G, van Koningsbruggen S, Wahn U, Ratjen F. Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 169: 719-25. PMID 14684561 DOI: 10.1164/Rccm.200307-959Oc |
0.483 |
|
| 2003 |
Midulla F, Blic Jd, Barbato A, Bush A, Eber E, Kotecha S, Haxby E, Moretti C, Pohunek P, Ratjen F. Flexible endoscopy of paediatric airways European Respiratory Journal. 22: 698-708. PMID 14582925 DOI: 10.1183/09031936.02.00113202 |
0.32 |
|
| 2003 |
Viazov S, Ratjen F, Scheidhauer R, Fiedler M, Roggendorf M. High prevalence of human metapneumovirus infection in young children and genetic heterogeneity of the viral isolates. Journal of Clinical Microbiology. 41: 3043-5. PMID 12843040 DOI: 10.1128/Jcm.41.7.3043-3045.2003 |
0.313 |
|
| 2003 |
Ratjen F, Döring G. Cystic fibrosis. Lancet (London, England). 361: 681-9. PMID 12606185 DOI: 10.1016/S0140-6736(03)12567-6 |
0.301 |
|
| 2003 |
Ratjen F, Costabel U, Griese M, Paul K. Bronchoalveolar lavage fluid findings in children with hypersensitivity pneumonitis. The European Respiratory Journal. 21: 144-8. PMID 12570123 DOI: 10.1183/09031936.03.00035703A |
0.334 |
|
| 2003 |
Grasemann H, Gravesande KSv, Büscher R, Knauer N, Silverman ES, Palmer LJ, Drazen JM, Ratjen F. Endothelial Nitric Oxide Synthase Variants in Cystic Fibrosis Lung Disease American Journal of Respiratory and Critical Care Medicine. 167: 390-394. PMID 12406848 DOI: 10.1164/Rccm.200202-155Oc |
0.347 |
|
| 2002 |
Griese M, Neumann M, Bredow Tv, Schmidt R, Ratjen F. Surfactant in children with malignancies, immunosuppression, fever and pulmonary infiltrates. European Respiratory Journal. 20: 1284-1291. PMID 12449186 DOI: 10.1183/09031936.02.00205702 |
0.338 |
|
| 2002 |
Baraldi E, de Jongste JC, Gaston B, Alving K, Barnes PJ, Bisgaard H, Bush A, Gaultier C, Grasemann H, Hunt JF, Kissoon N, Piacentini GL, Ratjen F, Silkoff P, Stick S. Measurement of exhaled nitric oxide in children, 2001 European Respiratory Journal. 20: 223-237. PMID 12166573 DOI: 10.1183/09031936.02.00293102 |
0.337 |
|
| 2002 |
Nikolaizik WH, Trociewicz K, Ratjen F. Bronchial reactions to the inhalation of high-dose tobramycin in cystic fibrosis. European Respiratory Journal. 20: 122-126. PMID 12166559 DOI: 10.1183/09031936.02.00264002 |
0.406 |
|
| 2002 |
Büscher R, Eilmes KJ, Grasemann H, Torres B, Knauer N, Sroka K, Insel PA, Ratjen F. beta2 adrenoceptor gene polymorphisms in cystic fibrosis lung disease. Pharmacogenetics. 12: 347-53. PMID 12142724 DOI: 10.1097/00008571-200207000-00002 |
0.435 |
|
| 2002 |
Neumann M, Bredow Cv, Ratjen F, Griese M. Bronchoalveolar lavage protein patterns in children with malignancies, immunosuppression, fever and pulmonary infiltrates Proteomics. 2: 683-689. PMID 12112849 DOI: 10.1002/1615-9861(200206)2:6<683::Aid-Prot683>3.0.Co;2-Z |
0.354 |
|
| 2002 |
Grasemann H, Gravesande KSv, Gärtig S, Kirsch M, Büscher R, Drazen JM, Ratjen F. Nasal nitric oxide levels in cystic fibrosis patients are associated with a neuronal NO synthase (NOS1) gene polymorphism. Nitric Oxide. 6: 236-241. PMID 11890749 DOI: 10.1006/Niox.2001.0408 |
0.417 |
|
| 2002 |
Gaston B, Ratjen F, Vaughan JW, Malhotra NR, Canady RG, Snyder AH, Hunt JF, Gaertig S, Goldberg JB. Nitrogen redox balance in the cystic fibrosis airway: effects of antipseudomonal therapy. American Journal of Respiratory and Critical Care Medicine. 165: 387-90. PMID 11818326 DOI: 10.1164/Ajrccm.165.3.2106006 |
0.456 |
|
| 2002 |
Döring G, Ratjen F, Nikolaizik W. Early Pseudomonas aeruginosa colonisation in cystic fibrosis patients The Lancet. 359: 626. DOI: 10.1016/S0140-6736(02)07727-9 |
0.448 |
|
| 2001 |
Ratjen F, Döring G, Nikolaizik WH. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis The Lancet. 358: 983-984. PMID 11583754 DOI: 10.1016/S0140-6736(01)06124-4 |
0.47 |
|
| 2001 |
Ratjen F, Comes G, Paul K, Posselt HG, Wagner TO, Harms K. Effect of continuous antistaphylococcal therapy on the rate of P. aeruginosa acquisition in patients with cystic fibrosis. Pediatric Pulmonology. 31: 13-6. PMID 11180669 DOI: 10.1002/1099-0496(200101)31:1<13::Aid-Ppul1001>3.0.Co;2-N |
0.366 |
|
| 2001 |
Ratjen F. Changes in strategies for optimal antibacterial therapy in cystic fibrosis. International Journal of Antimicrobial Agents. 17: 93-6. PMID 11165111 DOI: 10.1016/S0924-8579(00)00333-2 |
0.438 |
|
| 2001 |
Ratjen F, Kavuk I, Gärtig S, Wiesemann HG, Grasemann H. Airway nitric oxide in infants with acute wheezy bronchitis. Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology. 11: 230-5. PMID 11110577 DOI: 10.1034/J.1399-3038.2000.00093.X |
0.307 |
|
| 2001 |
Ratjen F. Pediatric pulmonary pearls. By Laura S. Inselman, M.D. Philadelphia, Hanley & Belfus, Inc., 2000, 224 pp. Pediatric Pulmonology. 32: 95-95. DOI: 10.1002/Ppul.1094 |
0.304 |
|
| 2000 |
Grasemann H, Knauer N, Büscher R, Hübner K, Drazen JM, Ratjen F. Airway nitric oxide levels in cystic fibrosis patients are related to a polymorphism in the neuronal nitric oxide synthase gene. American Journal of Respiratory and Critical Care Medicine. 162: 2172-6. PMID 11112133 DOI: 10.1164/Ajrccm.162.6.2003106 |
0.405 |
|
| 2000 |
de Blic J, Midulla F, Barbato A, Clement A, Dab I, Eber E, Green C, Grigg J, Kotecha S, Kurland G, Pohunek P, Ratjen F, Rossi G. Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. The European Respiratory Journal. 15: 217-31. PMID 10678650 DOI: 10.1183/09031936.00.15121700 |
0.316 |
|
| 2000 |
Ratjen F, Rietschel E, Griese M, Ballmann M, Kleinau I, Doring G, Reinhardt D, Paul K. Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function. Bronchoalveolar lavage for the evaluation of anti-inflammatory treatment (BEAT) study group European Respiratory Journal. 15: 141-145. PMID 10678636 DOI: 10.1183/09031936.00.15114100 |
0.471 |
|
| 2000 |
Eber E, Green C, Grigg J, Kotecha S, Kurland G, Pohunek P, Ratjen F, Rossi G. Bronchoalveolar lavage in children European Respiratory Journal. 15. DOI: 10.1034/J.1399-3003.2000.15A40.X |
0.317 |
|
| 2000 |
Ratjen F, Rietschel E, Griese M, Ballmann M, Kleinau I, Döring G, Reinhardt D, Paul K. Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function European Respiratory Journal. 15: 141-145. DOI: 10.1034/J.1399-3003.2000.15A26.X |
0.476 |
|
| 1999 |
Grasemann H, Gartig S, Wiesemann H, Teschler H, Konietzko N, Ratjen F. Effect of L-arginine infusion on airway NO in cystic fibrosis and primary ciliary dyskinesia syndrome European Respiratory Journal. 13: 114-118. PMID 10836334 DOI: 10.1183/09031936.99.13111499 |
0.439 |
|
| 1999 |
Grasemann H, Ratjen F. Cystic fibrosis lung disease: the role of nitric oxide. Pediatric Pulmonology. 28: 442-448. PMID 10587420 DOI: 10.1002/(Sici)1099-0496(199912)28:6<442::Aid-Ppul10>3.0.Co;2-4 |
0.335 |
|
| 1999 |
Grasemann H, Gaston B, Fang K, Paul K, Ratjen F. Decreased levels of nitrosothiols in the lower airways of patients with cystic fibrosis and normal pulmonary function Journal of Pediatrics. 135: 770-772. PMID 10586185 DOI: 10.1016/S0022-3476(99)70101-0 |
0.475 |
|
| 1999 |
Ratjen F, Gärtig S, Wiesemann HG, Grasemann H. Effect of inhaled nitric oxide on pulmonary function in cystic fibrosis. Respiratory Medicine. 93: 579-83. PMID 10542992 DOI: 10.1016/S0954-6111(99)90158-0 |
0.495 |
|
| 1999 |
Knauer-Fischer S, Ratjen F. Lipid-laden macrophages in bronchoalveolar lavage fluid as a marker for pulmonary aspiration. Pediatric Pulmonology. 27: 419-422. PMID 10380094 DOI: 10.1002/(Sici)1099-0496(199906)27:6<419::Aid-Ppul9>3.0.Co;2-U |
0.458 |
|
| 1999 |
Ratjen F, Tummler B. Comparison Of The In Vitro And In Vivo Response To Inhaled Dnase In Patients With Cystic Fibrosis Thorax. 54: 91-91. PMID 10343641 DOI: 10.1136/Thx.54.1.91 |
0.417 |
|
| 1999 |
Ratjen F, Havers W, Braun J. Intrapulmonary protein leakage in immunocompromised children and adults with pneumonia. Thorax. 54: 432-6. PMID 10212109 DOI: 10.1136/Thx.54.5.432 |
0.323 |
|
| 1999 |
Bauernfeind A, Jungwirth R, Ratjen F. Susceptibility of Pseudomonas aeruginosa isolates from cystic fibrosis patients to ciprofloxacin Drugs. 58: 209-210. DOI: 10.2165/00003495-199958002-00063 |
0.396 |
|
| 1998 |
Grasemann H, Ioannidis I, Tomkiewicz RP, De Groot H, Rubin BK, Ratjen F. Nitric oxide metabolites in cystic fibrosis lung disease Archives of Disease in Childhood. 78: 49-53. PMID 9534676 DOI: 10.1136/Adc.78.1.49 |
0.493 |
|
| 1998 |
Wiesemann HG, Steinkamp G, Ratjen F, Bauernfeind A, Przyklenk B, Döring G, von der Hardt H. Placebo-controlled, double-blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in cystic fibrosis. Pediatric Pulmonology. 25: 88-92. PMID 9516091 DOI: 10.1002/(Sici)1099-0496(199802)25:2<88::Aid-Ppul3>3.0.Co;2-J |
0.471 |
|
| 1997 |
Piotrowski JA, Splittgerber FH, Donovan TJ, Ratjen F, Zerkowski HR. Single-lung transplantation in a patient with cystic fibrosis and an asymmetric thorax Annals of Thoracic Surgery. 64: 1456-1459. PMID 9386721 DOI: 10.1016/S0003-4975(97)00925-9 |
0.424 |
|
| 1997 |
Grasemann H, Michler E, Wallot M, Ratjen F. Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis Pediatric Pulmonology. 24: 173-177. PMID 9330413 DOI: 10.1002/(Sici)1099-0496(199709)24:3<173::Aid-Ppul2>3.0.Co;2-O |
0.477 |
|
| 1997 |
Grasemann H, Ioannidis I, Groot Hd, Ratjen F. Metabolites of nitric oxide in the lower respiratory tract of children. European Journal of Pediatrics. 156: 575-578. PMID 9243246 DOI: 10.1007/S004310050667 |
0.371 |
|
| 1997 |
Rath P, Ratjen F, Ansorg R. Genetic diversity among isolates of Aspergillus fumigatus in patients with cystic fibrosis. Zentralblatt Fur Bakteriologie-International Journal of Medical Microbiology Virology Parasitology and Infectious Diseases. 285: 450-455. PMID 9084119 DOI: 10.1016/S0934-8840(97)80012-6 |
0.323 |
|
| 1996 |
Ratjen F, Bruch J. Adjustment of bronchoalveolar lavage volume to body weight in children Pediatric Pulmonology. 21: 184-188. PMID 8860074 DOI: 10.1002/(Sici)1099-0496(199603)21:3<184::Aid-Ppul6>3.0.Co;2-Q |
0.343 |
|
| 1996 |
Ratjen F, Rehn B, Costabel U, Bruch J. Age-dependency of surfactant phospholipids and surfactant protein A in bronchoalveolar lavage fluid of children without bronchopulmonary disease European Respiratory Journal. 9: 328-333. PMID 8777972 DOI: 10.1183/09031936.96.09020328 |
0.365 |
|
| 1996 |
Ratjen F, Costabel U, Havers W. Differential cytology of bronchoalveolar lavage fluid in immunosuppressed children with pulmonary infiltrates. Archives of Disease in Childhood. 74: 507-11. PMID 8758126 DOI: 10.1136/Adc.74.6.507 |
0.39 |
|
| 1995 |
Ratjen F, Bredendiek M, Brendel M, Meltzer J, Costabel U. Differential cytology of bronchoalveolar lavage fluid in normal children. The European Respiratory Journal. 7: 1865-70. PMID 7828697 DOI: 10.1183/09031936.94.07101865 |
0.394 |
|
| 1989 |
Ratjen F, Zinman R, Stark AR, Leszczynski LE, Wohl ME. Effect of changes in lung volume on respiratory system compliance in newborn infants. Journal of Applied Physiology (Bethesda, Md. : 1985). 67: 1192-7. PMID 2793712 DOI: 10.1152/Jappl.1989.67.3.1192 |
0.307 |
|
| 1985 |
Ratjen F, Wönne R, Posselt H-, Stöver B, Hofmann D, Bender SW. A double-blind placebo controlled trial with oral ambroxol and N-acetylcysteine for mucolytic treatment in cystic fibrosis. European Journal of Pediatrics. 144: 374-378. PMID 3908111 DOI: 10.1007/Bf00441781 |
0.448 |
|
| Show low-probability matches. |
